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We evaluated 25 protocol variants of 14 independent 
computational methods for exon identification, transcript 
reconstruction and expression-level quantification from  
rnA-seq data. our results show that most algorithms are able 
to identify discrete transcript components with high success 
rates but that assembly of complete isoform structures poses 
a major challenge even when all constituent elements are 
identified. expression-level estimates also varied widely 
across methods, even when based on similar transcript models. 
Consequently, the complexity of higher eukaryotic genomes 
imposes severe limitations on transcript recall and splice 
product discrimination that are likely to remain limiting  
factors for the analysis of current-generation rnA-seq data.
High-throughput sequencing instruments necessitate a shotgun 
approach for all but the shortest target molecules. Full-length 
representation of most cellular RNAs from sequencing data 
requires computational reconstruction of transcript structures. 
The majority of such programs infer transcript models from the 
accumulation of read alignments to the genome1–4; some take 
the alternative approach of de novo reconstruction, in which 
contiguous transcript sequences are assembled without the use 
of a reference genome5–7.
Here we present a detailed evaluation of computational 
methods for transcript reconstruction and quantification from 
RNA-seq data, in a framework based on the Encyclopedia of DNA 
Elements (ENCODE) Genome Annotation Assessment Project 
(EGASP)8. Developers of leading software programs were invited 
to participate in a consortium effort, the RNA-seq Genome 
Annotation Assessment Project (RGASP), to benchmark methods 
to predict and quantify expressed transcripts from RNA-seq data. 
Results were evaluated from methods based on genome align-
ments (Augustus9, Cufflinks3, Exonerate10, GSTRUCT, iReckon2, 
mGene11, mTim, NextGeneid12, SLIDE4, Transomics, Trembly 
and Tromer13) as well as de novo assembly (Oases5 and Velvet14). 
Our results identify aspects of RNA-seq analysis in which current 
approaches are relatively adept, along with more challenging areas 
for future improvement.
results
We evaluated a total of 25 transcript reconstruction protocols, 
basing our analysis on alternate parameter usage of 14 software 
packages on RNA-seq data sets for three species (Supplementary 
Fig. 1, Supplementary Table 1 and Supplementary Note). 
Programs were run by the original developers, with the excep-
tion of Cufflinks, iReckon and SLIDE. So that we could assess 
the ability of each method to interpret transcript expression from 
RNA-seq data without prior knowledge of gene content, pro-
grams were run without genome annotation, aside from iReckon 
and SLIDE, which require such information. Performance was 
benchmarked relative to the subset of annotated exons to which 
RNA-seq reads mapped (coverage of ≥1 read pair per 100 bp) and 
their corresponding transcripts (Online Methods).
identification of annotated features
We first assessed the degree to which gene components 
reported by each algorithm matched the reference annota-
tion at the nucleotide level. From the Caenorhabditis elegans 
data, the methods Augustus, mGene and Transomics displayed 
excellent performance in detecting exonic bases but also 
reported the expression of substantial proportions of genomic 
sequence outside of reference exons (Fig. 1 and Supplementary 
Table 2). Recall (sensitivity) was generally lower for Drosophila 
melanogaster, although most protocols exceeded 75% for both 
model organisms. Performance decreased for Homo sapiens 
data, for which trade-offs between precision and recall were 
more apparent. SLIDE and iReckon must be provided with gene 
annotation and therefore outperformed most other methods. 
Even so, iReckon attained low precision at the nucleotide level, 
primarily owing to the prediction of transcript isoforms with 
retained introns. Augustus, Exonerate, GSTRUCT, NextGeneid, 
Trembly and Velvet attained both precision and recall above 
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60% on the human data. The highest 
recall for methods without annotation 
was observed for Tromer and Cufflinks, 
albeit at the cost of low precision. These 
programs consistently displayed high sensitivity across the three 
species, but the precision rates for Tromer in particular indicate 
a tendency for overprediction.
exon identification from rnA-seq data
We assessed the ability of each method to identify individual 
exons from RNA-seq data relative to the reference annotation 
(Fig. 2). Inaccurate determination of transcription start and end 
sites is a known shortcoming of RNA-seq and, together with bio-
logical variation, impairs the identification of transcript bounda-
ries15–19. To mitigate this, we allowed the 5′ ends of first exons and 
3′ ends of terminal exons to differ from the reference coordinates 
(Online Methods and Supplementary Fig. 2). Without 
these relaxed criteria, agreement in transcription start site and 
polyadenylation site positioning between predicted and annotated 
exons was extremely rare (Supplementary Fig. 3). Similarly, pre-
diction accuracy for translation start and stop sites was lower than 
for internal exon boundaries, which can be inferred from spliced 
alignments (Supplementary Fig. 3 and Supplementary Table 3). 
Allowing for variable transcript boundaries led to substan-
tial improvements (Supplementary Tables 4 and 5). Although 
most protocols exhibited the lowest precision for the human 
RNA-seq data, for all three species, performance approached that 
of iReckon and SLIDE, despite the latter two benefiting from the 
use of high-quality gene annotation.
Coding exons can be identified directly from genomic sequence 
by the presence of translation start and stop sites and of splice 
acceptors and donors. Programs such as Augustus, Exonerate, 
mGene, NextGeneid, Tromer and Transomics use these features 
to improve exon discovery. Of these programs, Augustus, mGene 
and Transomics identified a greater proportion of annotated cod-
ing exons than did Exonerate, mTim, NextGeneid and Tromer 
(Supplementary Fig. 4). These methods augment data-driven 
transcript reconstruction with ab initio gene prediction, leading 
us to conclude that higher sensitivity measures are due to more 
extensive utilization of the underlying genomic sequence, which 
reduces the need for support from RNA-seq data.
We investigated the impact of sequencing depth on exon 
detection rates (Fig. 3a). Through the use of ab initio predic-
tion, Augustus, mGene and Transomics were able to detect exons 
from protein-coding transcripts present at very low abundance. 
All other methods required a minimum average read depth to 
identify exons. Exon detection increased 
with sampling coverage at a roughly linear 
rate until reaching a plateau. One excep-
tion was Tromer, which often reported 
short exon fragments of 50–75 bp flank-
ing introns without extending them to 
full exons (Supplementary Fig. 5). With 
increasing coverage, Tromer showed a ten-
dency to predict very long exons spanning 
multiple annotated features. To a lesser 
extent, Oases and Velvet also showed 
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Sensitivity PrecisionFigure 1 | Summary of nucleotide-level 
performance for the methods evaluated.  
The plots show performance at detecting exonic 
nucleotides. Sensitivity (blue) indicates the 
proportion of known exon sequence in each 
genome covered by assembled transcripts, and 
precision (orange) indicates the proportion of 
reported expressed sequence confined to known 
exons. Some protocol variants considered all 
expressed transcripts (all) or excluded those of 
low abundance (high). Programs run with gene 
annotation are grouped separately. iReckon was 
run with complete reference annotation (full) 
and with transcript boundaries only (ends). 
Transcript reconstruction methods are described 
in the supplementary note.
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Figure 2 | Summary of exon-level performance 
for the methods evaluated. The plots show 
performance at detecting individual exons 
as the percentage of reference exons with a 
matching feature in the submission (sensitivity, 
blue) and the proportion of reported exons that 
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reduced performance for high-coverage 
exons (Supplementary Fig. 6).
The ab initio prediction advantage of 
Augustus, mGene and Transomics was 
lost for noncoding transcripts, which 
lack the sequence features exploited 
by these methods (Supplementary 
Fig. 7). Nevertheless, detection rates 
were similar to those of other protocols 
(Supplementary Fig. 8). Noncoding RNAs 
tend to be expressed at lower levels than 
protein-coding genes (Supplementary 
Fig. 9) and were detected with lower sen-
sitivity even when we controlled for dif-
ferences in sequencing coverage (Fig. 3a 
and Supplementary Fig. 7). Exons of long intergenic noncoding 
RNAs were usually identified with lower frequency than those 
from pseudogenes and unclassified processed transcripts 
(Supplementary Fig. 10).
intron detection from rnA-seq data
The relative number and size of introns differ markedly between 
the three species used for this study (Supplementary Table 6). 
Overall Augustus, mGene and Transomics showed the highest 
intron detection rates (Fig. 3b). However, Transomics exhib-
ited a sharper decline with increased intron length. This trend 
was apparent for all methods except Tromer, for which a mark-
edly lower detection rate was observed for introns shorter than 
300 bp. To better characterize the differences in intron detec-
tion between methods, we classified reported introns on the 
basis of overlap with known splice sites (Fig. 4). Most protocols 
 predominantly detected known introns; several, however, also 
predicted a substantial number of introns with one or two 
novel splice sites. The highest frequencies of novel junctions 
were predicted by mGene, Transomics, Tromer, Velvet and the 
Augustus protocol that used only genomic sequence.
To explain this trend, we note that intron detection is highly 
dependent on the underlying read alignments and that some 
aligners are more conservative than others20. For example, 
PALMapper21 was used as the alignment component in the 
mGene and mTim protocols. This aligner places more reads 
across unannotated splice sites than do GEM22, GSNAP23 and 
TopHat24,25; the latter programs form part of the NextGeneid, 
GSTRUCT and Cufflinks protocols, respectively.
Assembly of exons into transcript isoforms
We next evaluated the performance of each method in linking exons 
into defined splice products. We initially determined the gene loci 
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Figure 3 | Influence of read depth and intron 
length on detection performance. (a) Sensitivity 
for detection of annotated exons stratified by 
read depth. (b) Annotated introns were binned 
on length, and sensitivity was calculated 
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valid transcript was identified, followed by 
those consistent with at least one anno-
tated isoform (Supplementary Fig. 11). 
Most algorithms detect transcription at 
over 80% of gene loci where expression 
is supported by RNA-seq reads. However, 
performance decreased substantially when 
genes were considered for which at least 
one annotated transcript had been identi-
fied. For unguided transcript reconstruc-
tion, valid isoforms were assembled for 
roughly half of expressed genes on aver-
age (H. sapiens mean 41%, maximum 61%; 
D. melanogaster mean 55%, maximum 73%; 
C. elegans mean 50%, maximum 73%), and 
for those only one isoform was typically 
identified (Supplementary Fig. 12).
A substantial reduction in sensitivity 
was also observed from the gene to 
transcript level, even when the flexible 
evaluation mode was used for first and 
terminal exons (Fig. 5a and Supplementary 
Table 5). The best-performing methods 
identified at most 56–59% of spliced 
protein-coding transcripts from C. elegans (Augustus, mGene and 
Transomics), 43% from D. melanogaster (Augustus) and merely 
21% from H. sapiens (Trembly). Sensitivity increased by roughly 
10% when partial isoform matches were considered, as did preci-
sion when partial predictions consistent with annotated isoforms 
were included (Fig. 5a).
Greater sequencing depth improved transcript assembly 
for D. melanogaster and C. elegans (Supplementary Fig. 13a), 
whereas in H. sapiens transcript detection remained low despite 
sequencing coverage in excess of 4,000 read pairs per kilobase 
in exonic regions. Generally, at least one consistent isoform was 
identified for highly expressed genes: >50% in D. melanogaster 
and C. elegans and >35% in H. sapiens (Supplementary 
Fig. 13b). Detection rates were even lower for noncoding RNAs 
(Supplementary Fig. 14). Pseudogenes were reported with similar 
frequency to that of protein-coding genes by Augustus, mGene, 
NextGeneid and Transomics, as pseudogenes retain partially 
intact coding sequences that can be identified by these methods 
(Supplementary Fig. 15).
The dramatic differences between species is further due to 
the tendency of methods to assign one splice product per gene 
(Supplementary Table 1). Whereas fewer than 25% of genes in 
C. elegans and D. melanogaster give rise to more than two tran-
script isoforms, human genes are annotated with an average of 
five, and it is unclear how many are simultaneously expressed. 
Assigning a single transcript model per gene will therefore impede 
the detection of multiple isoforms expressed in a given sample.
To identify the limiting factors in this process, for each method 
we calculated the number of known transcripts for which (i) all 
exons were identified, (ii) exactly one exon was missing, (iii) more 
than one exon was missing and (iv) no exons were detected at all 
(Fig. 5b). The results clearly show that missing exons severely 
compromised transcript identification. For a substantial percent-
age of transcripts, not all exons were identified, ranging from 
30% in C. elegans to greater than 60% in H. sapiens. Interestingly, 
although Trembly did not perform as well as Augustus, mGene 
and Transomics at the exon level, this method reported the highest 
number of transcripts for which all exons were represented from 
H. sapiens data. In contrast, Augustus, mGene and Transomics 
detected at least one exon for most transcripts. The remaining 
methods failed to identify any exons for nearly 20% of all tran-
scripts expressed in the RNA-seq data. SLIDE exhibited the same 
trend despite the provision of annotated exon coordinates.
We then examined the topology of transcript structures to 
determine how well each method was able to link exons into com-
plete isoforms. Even in cases in which all exons of an annotated 
transcript had been identified, full isoforms were often not assem-
bled (Supplementary Fig. 16). For C. elegans and D. melanogaster, 
most methods were able to reconstruct 60% of transcripts from the 
RNA-seq data. However, from the H. sapiens data, less than 40% of 
known transcripts were assembled. Tromer stands out as an excep-
tion: the program identified all exons for relatively few genes; but 
once accounted for, these were frequently linked into annotated 
transcript structures. Further inspection showed that these tended 
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Figure 5 | Transcript assembly performance. 
(a) Reference transcripts with a matching 
submission entry (transcript-level sensitivity, 
blue) and reported transcripts that match the 
reference (transcript-level precision, orange). 
(b) Transcripts for which various subsets of 
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to be short isoforms comprising 2–3 exons on average and thus 
represent a more tractable subset of the transcriptome.
Provision of transcript start and end sites gave iReckon an 
advantage for the more complex human transcriptome, as 
 evidenced by increased accuracy in assembling partial transcripts. 
In contrast, SLIDE consults exon coordinates but ignores their 
connectivity, performing at a level similar to methods without any 
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Figure 6 | Examples of transcript calls and expression-level estimates. (a) The upper tracks show RNA-seq read coverage (from STAR alignments;  
see Online Methods) and annotated genes. Exon predictions from the ten methods that quantified transcripts are illustrated below the annotated gene 
by colored boxes. Exons predicted to belong to the same transcript isoform are connected. Original and median-scaled RPKM values are presented to the 
right and left, respectively, of the transcript models. For the gene RPF2, all methods reported different isoforms and expression levels. Where multiple 
overlapping isoforms were identified, that with the higher RPKM was selected for visualization, and spliced isoforms were prioritized over unspliced  
ones. The noncoding RNA U6 is not expressed. (b) Heat maps illustrate pairwise agreement between reported transcript isoforms for H. sapiens (left),  
D. melanogaster (center) and C. elegans (right). (c) Correlation between reported RPKM values and NanoString counts (Pearson r of log-transformed 
values). NanoString counts were compared to the highest RPKM value reported for transcript isoforms consistent with the probe design (correlation rc) or 
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often differed substantially (Fig. 6a), and few were consistent 
across all methods (Supplementary Fig. 17). Pairwise agreement 
(Fig. 6b) was markedly higher for the model organisms than for 
human (median 25%), reflecting the number of partial isoforms 
identified as a function of transcriptome complexity.
Quantification of expression levels from rnA-seq data
A common feature of transcript reconstruction software is the 
estimation of expression levels from transcribed genes. These are 
given as digital read counts normalized by transcript length and 
sequencing depth (reads per kilobase of exon model per million 
mapped reads, RPKM)26. RPKM values were reported at the tran-
script level from a subset of methods. A range of expression-level 
distributions was evident (Supplementary Fig. 18), but generally 
there was strong agreement among Augustus, iReckon, mGene 
and Trembly for all three RNA-seq data sets (Supplementary 
Figs. 19–22). One source of variation arises from gene loci 
where divergent or incomplete transcript models have been com-
puted (Fig. 5a and Supplementary Figs. 23 and 24). However, 
expression-level estimates can vary considerably even where 
concordant transcript structures are reported (Supplementary 
Fig. 17). Such differences were also apparent after we scaled the 
RPKM distributions to equalize median expression values.
To establish independent expression-level quantification, we 
assayed a set of human genes using the NanoString nCounter ampli-
fication-free detection system27 (Supplementary Tables 7–9). 
Correlation between NanoString counts and RNA-seq RPKMs 
ranged from 0.34 for Transomics to 0.68 for Cufflinks (Fig. 6c and 
Supplementary Fig. 25). Many methods failed to report numer-
ous targeted exons or junctions that were expressed according 
to NanoString counts. Read support at those loci was typically 
sparse, with 19 probes having no corresponding alignments 
from the RNA-seq data. These were, however, represented by 
low NanoString counts, which indicated that the nCounter assay 
exhibits higher sensitivity for low-abundance transcripts than 
RNA-seq (Supplementary Fig. 26). For ten of the unsupported 
NanoString probes, consistent isoforms were still reported by 
either Augustus, iReckon, mGene, SLIDE or Transomics. Thus, 
although the expression levels of these genes reflect the lower lim-
its of detection for both technologies, sequencing reads dispersed 
over the gene body can allow for adequate transcript identifica-
tion where ab initio methods or gene annotation were applied.
In general, all methods displayed higher identification rates 
for exons and junctions with higher NanoString counts, and reli-
able detection from RNA-seq data was dependent on read depth 
(Supplementary Fig. 27). Nonetheless, each failed to report a 
subset of exons and junctions despite the availability of adequate 
RNA-seq alignments (Supplementary Fig. 27b). Comparing 
NanoString counts with RPKM values of the predominant iso-
form reported for each gene (irrespective of whether the targeted 
exon or junction was identified) improved correlation for most 
methods and did so substantially for mTim and Transomics 
(Fig. 6c and Supplementary Fig. 28).
disCussion
Technical limitations imposed by short-read sequencing lead to 
a number of computational challenges in transcript reconstruc-
tion and quantification. Methods that combine ab initio predic-
tion with experimental data were more effective at detecting 
genes expressed at low abundance or genes from samples with 
low sequencing coverage. Even so, the benefits of this approach 
lessened with increased transcriptome complexity.
These results underscore the difficulty of transcript assembly. 
For most transcripts, automated methods failed to identify all con-
stituent exons, and in cases in which all exons were reported, the 
protocols tested often failed to assemble the exons into complete 
isoforms. Whereas methods using ab initio prediction retained an 
advantage in detecting individual exons, others performed better 
at linking them together. No single protocol excelled at all met-
rics. Comparing the performance of Augustus with and without 
RNA-seq data as input revealed that using experimental evidence 
only slightly improved exon-level detection but increased tran-
script-level precision. Transomics featured enhanced precision 
for high-abundance transcripts, but expression-level differences 
had little impact on detection sensitivity. Precision was a consist-
ent strength of GSTRUCT, whereas mGene exhibited diminished 
performance on human RNA-seq data, a result underscoring that 
choice of method can depend on the organism under study.
Considerable variation was observed in the range of expres-
sion-level estimates reported for transcripts arising from the 
same gene loci. This was exacerbated by nonuniform exon detec-
tion and linkage between methods but was also apparent when 
similar or identical transcript structures were reported. Thus, it 
may be unreliable to directly compare gene-based RPKM values 
from sample data processed independently with different soft-
ware tools. RNA-seq data to be compared from disparate sources 
should be treated in an identical manner from the initial process-
ing steps. When this is not possible, care should be taken to ensure 
that similar gene models have been identified, and RPKM distri-
butions should be inspected before expression-level thresholds 
are applied in downstream analyses. Alternatively, uniform 
quantification of predicted transcripts can be performed with 
dedicated software28–30.
The potential for noncoding RNA discovery and characteriza-
tion is a distinct advantage of RNA-seq over gene-based expres-
sion profiling. However, this remains a challenging area for 
automated analysis methods. Performance is often impaired by 
lower expression levels of noncoding transcripts relative to that 
of many protein-coding genes, coupled with the inherent lack 
of translational features at the sequence level. The presence of 
open reading frames and translation start and stop signals allowed 
some methods to identify protein-coding transcripts even at very 
low expression levels, whereas the detection of noncoding RNAs 
at high confidence required much greater read depth. Sequencing 
coverage thus appears to be crucial for accurate noncoding 
RNA analysis.
The methods evaluated here can be applied to a range of anal-
ysis strategies, largely dependent on the state of the reference 
genome assembly and associated gene annotation for the target 
species (Supplementary Table 10 and Supplementary Note). To 
improve the accuracy of existing annotation using RNA-seq data, 
both Cufflinks and iReckon consult known gene structures dur-
ing the transcript assembly process and may be useful in refining 
the coordinates of exon and transcript boundaries. Where a fin-
ished genome and high-quality annotation are available, Cufflinks 
and rQuant (part of the mGene protocol) can be applied solely 
for transcript quantification, which can be further improved by 
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as Augustus and mGene can be used to automate the annota-
tion of novel genomes, whereas RNA-seq experiments based on 
partial or low-quality genome builds can be approached with a 
de novo assembler such as Oases. This last application is expected 
to receive increasingly wider attention with the continued 
sequencing of new genomes.
RNA-seq offers the potential to refine existing gene annota-
tion through the discovery of novel exons and junction sites. 
However, unannotated transcript isoforms assembled from 
RNA-seq data should be interpreted with care, and those 
critical to an experimental study should be subjected to independ-
ent validation. The expression of multiple transcript isoforms 
and novel splice variants presents a major obstacle to accurate 
transcriptome reconstruction. Both exon identification and novel 
RNA discovery can improve with increased read depth, but the 
benefits of additional sampling to transcript assembly are inher-
ently limited by the library construction requirements of current 
high-throughput sequencing platforms. Ultimately, the evolution 
of RNA-seq will move toward single-pass determination of intact 
transcripts. Third-generation instruments will realize that poten-
tial and inspire new computing approaches to meet the next wave 
of innovation in transcriptome analysis.
methods
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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RNA-seq data. RNA-seq data were generated as part of the 
ENCODE31 and modENCODE projects32, along with a third 
data set of compatible sequencing format and read depth, 
and represent three widely studied species: H. sapiens (liver 
hepatocellular carcinoma cell line HepG2)33, D. melanogaster  
(L3 stage larvae)34, and C. elegans (L3 stage larvae)35. These were 
chosen to reflect realistic examples of varying transcriptome 
complexity and where high-quality annotated reference genomes 
are available. Libraries were prepared for the Illumina platform 
and sequenced in 76-nt paired-end format to obtain approxi-
mately 100 million read pairs per sample.
H. sapiens RNA-seq data correspond to ENCODE33 HepG2 
whole-cell long poly(A)+ RNA CALTECH replicate 2, avail-
able from http://www.encodeproject.org/. The D. melanogaster 
data set comprised a total of five sequencing runs from the 
modENCODE project34 for three L3 stage larval samples and 
can be obtained from the Sequence Read Archive (http://www.
ncbi.nlm.nih.gov/sra) under accession numbers SRR023546, 
SRR023608, SRR023505, SRR027108 and SRR026433. The 
C. elegans RNA-seq data have previously been described35 and are 
available under accession SRR065719. All of the data used in this 
study have been consolidated as a single experimental record in 
the ArrayExpress repository (http://www.ebi.ac.uk/arrayexpress/) 
under accession E-MTAB-1730.
Reference gene annotation. As not all genes are expressed in 
the samples used in the study, benchmarking methods against 
the entire set of annotated genes would underestimate transcript 
detection sensitivity. Therefore, we processed the genome anno-
tations (H. sapiens: GENCODE31 v.15 (Ensembl release 70), 
D. melanogaster: FB2013_01, C. elegans: WS200) to include only 
exons and transcripts with sufficient support in the RNA-seq data. 
Reads were mapped to the reference genomes using STAR version 
2.2.0c, an independent RNA-seq aligner that is not a component 
in any of the evaluated transcript assembly methods36. To improve 
spliced alignment, STAR was provided with exon junction coordi-
nates from the reference annotations. Default alignment param-
eters were used for the human data. For D. melanogaster and 
C. elegans, the intron size limit was reduced to 100,000 and 
15,000 respectively (using options -alignIntronMax and 
-alignMatesGapMax). For each annotated exon, the read coverage 
(number of uniquely mapped read pairs divided by exon length) 
was computed, and exons with a value below 0.01 fragments per 
base pair were excluded from further analysis. Only transcripts for 
which all exons satisfied this criterion were included in transcript-
level assessments. The threshold was determined by examining 
the exonic read coverage distribution, which consisted of three 
main features: a small peak at the low end (coverage < 0.01 frag-
ments per base pair), a dominant peak (coverage > 0.1) and a 
shoulder in between. Inspection of read alignments suggested that 
spurious reads are overrepresented in the minor peak, whereas the 
shoulder region comprises low-abundance transcripts and 
was therefore included in the analysis. To rule out poten-
tial bias imparted by the choice of alignment program, we 
calculated sensitivity and precision metrics for expressed 
genes using several different spliced aligners (GSNAP, STAR 
and TopHat2), with no substantial change to the results 
(Supplementary Figs. 29–31).
Transcript prediction and assembly. Developer teams were 
provided with RNA-seq data and reference genome sequences 
for each species. So that we avoided potential biases, teams 
were not informed of the final evaluation criteria and were not 
provided with gene annotation unless otherwise noted (for 
example, iReckon and SLIDE). Developers providing transcript 
models for evaluation could not access submissions from other 
teams and were prohibited from participating in the analysis phase 
as part of the study design. Details of transcript reconstruction 
protocols are provided in the Supplementary Note.
Data processing for Cufflinks, iReckon and SLIDE. RNA-seq 
reads were aligned with TopHat version 2.0.3 using parameters 
suited to each species. The genomes of D. melanogaster and 
C. elegans contain a high percentage of small introns 
(Supplementary Table 2); examining their size distributions 
led us to set the parameters -i, -min-coverage-intron and -min- 
segment-intron to 30 for C. elegans, 40 for D. melanogaster and 
50 for H. sapiens.
Cufflinks was run with default settings except for the parameter 
-min-intron-length, which was set to 30 for C. elegans, 40 for 
D. melanogaster and 50 for H. sapiens, consistent with the TopHat 
alignments. So that we maintained the greatest compatibility with 
submitted results that were computed without annotation. The 
protocol iReckon ends was run with the minimum annotation 
requirements, i.e., start and end sites of all annotated transcripts 
(not filtered by read coverage), whereas iReckon full was pro-
vided with the complete reference annotation. SLIDE was run in 
discovery mode and provided with the full unfiltered annotation 
for each genome.
Evaluation of prediction sets. Feature predictions were evaluated 
against the filtered reference annotation sets at four structural 
levels: nucleotide, exon, transcript and gene. The nucleotide-level 
metrics measure the ability of methods to identify exonic regions, 
ignoring the strand and exact boundaries of features. Nucleotide-
level precision was computed as the number of genomic base 
pairs within both annotated and predicted exons, divided by the 
number of genomic base pairs within predicted exons. Similarly, 
nucleotide recall was computed as the number of genomic base 
pairs shared between annotated and predicted exons, divided by 
the number of genomic base pairs within annotated exons.
The exon-level metrics measure the ability of the different algo-
rithms to identify the correct strand and boundaries of exons. 
Precision was calculated as the percentage of reported exons with 
an annotated counterpart, and recall denotes the percentage of 
annotated exons that were correctly assembled. Annotated exons 
were classified as first, internal, terminal and those comprising 
unspliced transcripts (single exons). Unless stated otherwise, 
a flexible evaluation mode was employed for first, terminal and 
single exons. Specifically, first and terminal exons were required 
to have correctly predicted internal borders only, and exons consti-
tuting unspliced transcripts were scored as correct if covered to at 
least 60% by a predicted transcript. Exons shared between different 
transcript isoforms were counted once. For comparison, certain 
analyses were also carried out using a fixed evaluation mode, where 
annotated and predicted exons were required to match exactly.
Transcript-level precision was computed as the percentage of 



























and recall as the percentage of annotated spliced transcripts with 
a counterpart in the transcript reconstruction output. Consistent 
with the flexible evaluation mode for exons (see above), transcript 
start and end sites were allowed to differ between reference and 
prediction, but splice sites were required to match exactly. Genes 
were scored as correctly predicted if at least one annotated tran-
script isoform in a given gene locus was correct. To estimate the 
degree of similarity between transcript predictions, we calculated 
a pairwise agreement score. The score a[i,j] denotes the fraction 
of transcription products predicted by protocol i consistent with 
those from protocol j. Methods were ordered by hierarchical 
clustering based on the distance metric 1 – (a[i,j] + a[j,i])/2.
Evaluation of transcript quantification. To compare tran-
script quantification results between methods, we identified 
for each annotated gene the corresponding predominant tran-
script reported; this was defined as the transcript with the high-
est reported RPKM value among those isoforms intersecting 
annotated exons of the gene. A subset of human transcripts was 
quantified independently by NanoString assays. Genes of at least 
1 kb in length, for which annotated exon-intron structures have 
been manually curated, and having at least two transcripts sat-
isfying these criteria were selected. A total of 109 genes were 
 targeted by 141 distinct probes, designed against specific exons or 
splice junctions.
NanoString counts were compared to the highest RPKM value 
reported for transcript isoforms consistent with the probe design 
(correlation rc) or for any isoform from the locus (correlation ra). 
Predicted transcripts were required to contain the exon or junc-
tion targeted by the NanoString probe. Where multiple such 
transcripts were reported for the same gene, the highest RPKM 
value was used. Where no such transcript was reported, an 
RPKM of 0 was assigned. Percentages reflect the probes for which 
transcripts satisfying these criteria were reported. Pearson’s r was 
calculated on the basis of the log-transformed NanoString counts 
and RNA-seq RPKM values. Expression values were incremented 
by 1 before transformation to avoid infinite numbers.
Software availability. Source code for the evaluations performed 
in this study can be obtained from https://github.com/RGASP-
consortium/.
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Supplementary	  Figure	  1.	  Frequency	  of	  alternative	  splicing	  events.	  Bars	  show	  the	  percentage	  of	  genes	  with	  the	  indicated	  number	  of	  alternative	  splicing	  events	  in	  the	  reference	  annotation.	  Events	  were	  counted	  by	  analysis	  of	  annotated	  transcripts	  to	  identify	  skipped	  exons,	  retained	  introns,	  and	  alternative	  donor	  and	  acceptor	  sites.	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Supplementary	  Figure	  2.	  Structural	  validation	  strategy.	  Transcript	  models	  were	  validated	  against	  annotated	  isoforms.	  For	  exon-­‐level	  evaluation,	  transcripts	  were	  collapsed	  into	  unique	  exon	  sets,	  i.e.	  exons	  shared	  between	  transcript	  isoforms	  are	  counted	  once.	  Sensitivity	  (a.k.a.	  recall)	  was	  calculated	  as	  the	  proportion	  of	  reference	  features	  (exons,	  transcripts,	  or	  genes)	  matched	  by	  a	  reported	  feature.	  Precision	  was	  calculated	  as	  the	  proportion	  of	  reported	  features	  matching	  a	  reference	  feature.	  We	  primarily	  used	  a	  flexible	  evaluation	  strategy	  where	  exact	  agreement	  between	  transcript	  boundaries	  was	  not	  required.	  For	  comparison,	  certain	  analyses	  were	  also	  carried	  out	  using	  a	  fixed	  evaluation	  mode,	  where	  annotated	  and	  predicted	  exons	  were	  required	  to	  match	  exactly.	  See	  Methods	  for	  further	  details.	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Supplementary	  Figure	  3.	  Influence	  of	  exon	  rank	  on	  detection	  performance.	  Results	  are	  shown	  for	  D.	  melanogaster	  (a)	  and	  C.	  elegans	  (b).	  Annotated	  exons	  were	  classified	  as	  first,	  internal,	  terminal	  or	  single	  (i.e.,	  those	  comprising	  an	  entire	  transcript)	  and	  sensitivity	  calculated	  separately	  for	  each	  class.	  Exon	  boundaries	  were	  required	  to	  be	  predicted	  exactly	  as	  annotated	  (left,	  center)	  or	  according	  to	  relaxed	  criteria	  for	  the	  external	  transcript	  boundaries	  (right).	  Programs	  run	  with	  reference	  annotation	  are	  grouped	  separately	  (lower	  tracks).	  As	  SLIDE	  is	  provided	  with	  full	  gene	  annotation	  as	  a	  requirement,	  those	  protocols	  do	  not	  display	  a	  strong	  preference	  for	  internal	  exons.	  Several	  methods	  were	  unable	  to	  accurately	  determine	  the	  strand	  orientation	  for	  unspliced	  transcripts,	  resulting	  in	  low	  sensitivity	  for	  constituent	  exons.	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Supplementary	  Figure	  4.	  Performance	  at	  detecting	  individual	  coding	  exons.	  Points	  indicate	  the	  percentage	  of	  reference	  coding	  exons	  with	  a	  matching	  feature	  in	  the	  submitted	  transcript	  models	  (recall,	  green),	  and	  the	  proportion	  of	  reported	  coding	  exons	  that	  agree	  with	  annotation	  (precision,	  red).	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Supplementary	  Figure	  5.	  Exon	  length	  distributions	  in	  transcriptome	  assembly	  results.	  Colors	  indicate	  percentage	  of	  exons	  within	  the	  indicated	  length	  intervals.	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Supplementary	  Figure	  6.	  Internal	  exon	  detection	  rate	  stratified	  by	  read	  coverage.	  Bars	  indicate	  the	  percentage	  of	  annotated	  internal	  exons	  (of	  human	  protein-­‐coding	  genes)	  that	  overlap	  with	  reported	  exons.	  Reference	  exons	  were	  binned	  by	  read	  coverage	  (x	  axis)	  and	  further	  classified	  based	  on	  overlap	  with	  predicted	  exons	  (inset	  legend).	  Specifically,	  the	  classes	  represent	  exons	  with	  a	  perfectly	  matching	  prediction	  (green);	  exons	  for	  which	  all	  overlapping	  predictions	  span	  a	  larger	  region,	  including	  the	  entire	  reference	  exon	  (dark	  blue);	  exons	  for	  which	  all	  overlapping	  predictions	  are	  contained	  within	  the	  reference	  exon	  (light	  blue);	  and	  exons	  with	  other	  or	  multiple	  overlap	  types	  (pink).	  Note	  the	  decrease	  in	  detection	  performance	  at	  high	  read	  coverage	  for	  Oases,	  Velvet	  and	  SLIDE,	  as	  well	  as	  the	  high	  frequency	  of	  imperfect	  overlaps	  for	  Tromer.	  See	  also	  Figure	  2b.
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Supplementary	  Figure	  7.	  Influence	  of	  sequencing	  coverage	  on	  non-­‐coding	  exon-­‐level	  sensitivity.	  Annotated	  exons	  of	  non-­‐coding	  transcripts	  were	  binned	  according	  to	  RNA-­‐seq	  read	  coverage	  and	  method	  sensitivities	  were	  calculated	  for	  each	  bin	  separately.	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Supplementary	  Figure	  8.	  Exon	  detection	  sensitivity	  relative	  to	  coding	  potential.	  Percentage	  of	  detected	  exons	  belonging	  to	  coding	  (green)	  and	  non-­‐coding	  (red)	  transcripts	  in	  H.	  sapiens	  and	  D.	  melanogaster.	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Supplementary	  Figure	  9.	  RNA-­‐seq	  read	  coverage	  for	  exons	  of	  coding	  and	  non-­‐coding	  transcripts.	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Supplementary	  Figure	  10.	  Exon	  detection	  sensitivity	  for	  non-­‐coding	  genes.	  (a)	  Non-­‐coding	  transcripts	  expressed	  in	  the	  human	  RNA-­‐seq	  data	  set,	  annotated	  by	  gene	  biotype.	  (b)	  Detected	  exons	  from	  transcripts	  of	  non-­‐coding	  gene	  biotypes.	  Small	  RNAs	  were	  excluded,	  as	  they	  are	  underrepresented	  in	  data	  sets	  derived	  from	  standard	  mRNA-­‐seq	  protocols	  that	  incorporate	  poly(A)	  selection.	  Alternative	  library	  construction	  protocols	  are	  required	  to	  specifically	  interrogate	  small	  RNA	  populations.
Nature Methods: doi:10.1038/nmeth.2714
Steijger	  et	  al.	   Supplement	  
Page 12 of 53	  
 
 
Supplementary	  Figure	  11.	  Gene	  detection	  performance.	  Points	  indicate	  the	  percentage	  of	  reference	  genes	  	  with	  a	  matching	  assembled	  transcript	  (recall,	  green)	  and	  reported	  genes	  with	  at	  least	  one	  transcript	  matching	  the	  reference	  (precision,	  red).	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Supplementary	  Figure	  12.	  Number	  of	  isoforms	  detected	  per	  gene.	  Genes	  with	  at	  least	  three	  annotated	  splice	  products	  for	  which	  various	  subsets	  have	  been	  reported.	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Supplementary	  Figure	  13.	  Influence	  of	  read	  depth	  on	  transcript-­‐level	  (a)	  and	  gene-­‐level	  (b)	  sensitivity.	  Annotated	  transcripts	  and	  genes	  were	  binned	  according	  to	  RNA-­‐seq	  read	  coverage	  and	  method	  sensitivities	  were	  calculated	  for	  each	  bin	  separately.	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Supplementary	  Figure	  14.	  Transcript	  level	  performance	  for	  coding	  and	  non-­‐coding	  transcripts.	  Percentage	  of	  transcripts	  annotated	  in	  H.	  sapiens	  and	  D.	  melanogaster	  matching	  a	  reported	  transcript.	  Note,	  SLIDE	  shows	  higher	  sensitivity	  for	  non-­‐coding	  transcripts	  as	  these	  tend	  to	  be	  shorter	  than	  protein	  coding	  transcripts.	  For	  transcripts	  with	  a	  given	  number	  of	  exons	  SLIDE	  identifies	  more	  protein	  coding	  than	  non-­‐coding	  transcripts.	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Supplementary	  Figure	  15.	  Transcript	  detection	  sensitivity	  for	  non-­‐coding	  genes.	  Transcripts	  identified	  in	  the	  human	  data	  set	  annotated	  by	  non-­‐coding	  gene	  biotype.	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Supplementary	  Figure	  16.	  Transcript	  assembly	  performance.	  Percentage	  of	  transcripts,	  for	  which	  all	  exons	  have	  been	  identified,	  that	  were	  correctly	  assembled	  to	  a	  full-­‐length	  annotated	  splice	  variant.	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Supplementary	  Figure	  17.	  Transcript	  predictions	  and	  expression	  level	  estimates	  (in	  RPKM)	  at	  the	  COX5B	  locus.	  Upper	  tracks	  depict	  RNA-­‐seq	  read	  coverage	  (from	  STAR	  alignments;	  see	  Methods)	  and	  annotated	  genes.	  Exon	  predictions	  from	  the	  10	  methods	  that	  provided	  RPKM	  values	  are	  illustrated	  below	  the	  annotated	  gene	  by	  colored	  boxes.	  Exons	  reported	  as	  part	  the	  same	  transcript	  isoform	  are	  connected.	  iReckon	  full	  does	  not	  predict	  retained	  introns	  for	  this	  gene.	  Original	  and	  median-­‐scaled	  RPKMs	  are	  presented	  to	  the	  right	  and	  left,	  respectively.	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Supplementary	  Figure	  18.	  Distribution	  of	  gene	  expression	  values	  (RPKM)	  for	  each	  method.	  Results	  are	  shown	  for	  annotated	  genes	  only.	  Where	  multiple	  transcripts	  were	  reported	  for	  the	  same	  gene,	  the	  highest	  RPKM	  value	  was	  used,	  corresponding	  to	  the	  predominant	  transcript	  identified	  by	  each	  method.	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Supplementary	  Figure	  19.	  Pairwise	  agreement	  between	  methods.	  Lower	  triangles	  show	  expression	  correlation	  (Pearson	  r	  of	  log	  RPKM)	  for	  the	  set	  of	  genes	  identified	  by	  all	  methods.	  Upper	  triangles	  depict	  the	  proportion	  of	  genes	  shared	  between	  each	  method	  pair,	  i.e.	  the	  number	  of	  genes	  identified	  as	  expressed	  in	  both	  divided	  by	  number	  of	  genes	  identified	  as	  expressed	  in	  either.	  Methods	  were	  ordered	  by	  hierarchical	  clustering	  using	  1–r	  as	  the	  distance	  metric.	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Supplementary	  Figure	  20.	  Comparison	  of	  quantification	  methods	  for	  H.	  sapiens.	  For	  each	  pair	  of	  methods,	  scatter	  plots	  relate	  log2	  RPKM	  values	  for	  the	  genes	  identified	  by	  all	  methods.	  The	  corresponding	  correlation	  coefficients	  (Pearson	  r)	  are	  shown	  opposite.	  Where	  multiple	  transcripts	  were	  reported	  for	  the	  same	  gene,	  the	  highest	  RPKM	  value	  was	  used,	  corresponding	  to	  the	  predominant	  transcript	  identified	  by	  each	  method.	  RPKM	  values	  for	  AUGUSTUS,	  iReckon,	  SLIDE,	  Transomics	  and	  Trembly	  correspond	  to	  the	  values	  reported	  by	  their	  ‘all’,	  and	  ‘full’	  protocols.	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Supplementary	  Figure	  21.	  Comparison	  of	  quantification	  methods	  for	  D.	  melanogaster.	  See	  Supplementary	  Figure	  20	  for	  details.	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Supplementary	  Figure	  22.	  Comparison	  of	  quantification	  methods	  for	  C.	  elegans.	  See	  Supplementary	  Figure	  20	  for	  details.	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Supplementary	  Figure	  23.	  Transcript	  predictions	  and	  expression	  level	  estimates	  (in	  RPKM)	  at	  the	  CDC42	  locus.	  Upper	  tracks	  depict	  RNA-­‐seq	  read	  coverage	  (from	  STAR	  alignments;	  see	  Methods)	  and	  annotated	  genes.	  Exon	  predictions	  from	  the	  10	  methods	  that	  provided	  RPKM	  values	  are	  illustrated	  below	  the	  annotated	  gene	  by	  colored	  boxes.	  Exons	  reported	  as	  part	  the	  same	  transcript	  isoform	  are	  connected.	  iReckon	  full	  does	  not	  predict	  retained	  introns	  for	  this	  gene.	  Original	  and	  median-­‐scaled	  RPKMs	  are	  presented	  to	  the	  right	  and	  left,	  respectively.	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Supplementary	  Figure	  24.	  Transcript	  predictions	  and	  expression	  level	  estimates	  (in	  RPKM)	  at	  the	  EIF1AX	  locus.	  	  See	  Supplementary	  Fig.	  23	  for	  details.	  iReckon	  full	  does	  not	  predict	  retained	  introns	  for	  this	  gene.	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Supplementary	  Figure	  25.	  Correlation	  between	  NanoString	  counts	  and	  transcript	  RPKMs.	  Scatter	  plots	  show	  individual	  data	  points	  in	  black,	  with	  color	  intensity	  indicating	  the	  density	  of	  data	  points.	  Predicted	  transcripts	  were	  required	  to	  contain	  the	  exon	  or	  junction	  targeted	  by	  the	  NanoString	  probe.	  Where	  multiple	  such	  transcripts	  were	  reported	  for	  the	  same	  gene,	  the	  highest	  RPKM	  value	  was	  used.	  Where	  no	  such	  transcript	  was	  reported,	  an	  RPKM	  of	  zero	  was	  assigned.	  Correlation	  coefficients	  (Pearson	  r)	  are	  given	  for	  each	  comparison.	  Expression	  values	  were	  incremented	  by	  1	  prior	  to	  log	  transformation	  to	  avoid	  infinite	  numbers.	  Notably,	  the	  protocol	  iReckon	  ends	  identifies	  more	  genes	  than	  iReckon	  full.	  When	  provided	  with	  complete	  gene	  annotation,	  iReckon	  often	  fails	  to	  resolve	  transcripts	  in	  complex	  loci	  with	  many	  annotated	  isoforms.	  This	  occurs	  less	  frequently	  when	  the	  program	  is	  given	  only	  transcript	  boundaries.	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Supplementary	  Figure	  26.	  Correlation	  between	  NanoString	  counts	  and	  numbers	  of	  mapped	  reads	  for	  targeted	  exons	  and	  junctions.	  Scatter	  plots	  show	  individual	  data	  points	  in	  red	  (Tophat)	  and	  blue	  (STAR).	  Count	  values	  were	  incremented	  by	  1	  prior	  to	  log	  transformation	  to	  avoid	  infinite	  numbers.	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Supplementary	  Figure	  27.	  Distribution	  of	  NanoString	  counts	  (a)	  and	  mapped	  reads	  by	  the	  STAR	  aligner	  (b)	  for	  probes	  depending	  on	  whether	  a	  method	  identified	  an	  isoform	  consistent	  with	  a	  probe	  (left)	  or	  not	  (right).	  Both	  mTim	  and	  Transomics	  failed	  to	  identify	  many	  exons	  or	  junctions	  targeted	  by	  NanoString	  probes	  with	  RNA-­‐seq	  read	  support.	  Count	  values	  were	  incremented	  by	  1	  prior	  to	  log	  transformation	  to	  avoid	  infinite	  numbers.	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Supplementary	  Figure	  28.	  Correlation	  between	  NanoString	  counts	  and	  gene	  RPKMs.	  Scatter	  plots	  show	  individual	  data	  points	  in	  black,	  with	  color	  intensity	  indicating	  the	  density	  of	  data	  points.	  Where	  multiple	  transcripts	  were	  reported	  for	  the	  same	  gene,	  the	  highest	  RPKM	  value	  was	  used	  (irrespective	  of	  whether	  that	  transcript	  contained	  the	  exon	  or	  junction	  targeted	  by	  the	  NanoString	  probe).	  Correlation	  coefficients	  (Pearson	  r)	  are	  given	  for	  each	  comparison.	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Supplementary	  Figure	  29.	  Influence	  of	  different	  aligners	  on	  annotation	  usage	  (H.	  sapiens).	  Exon,	  transcript	  and	  gene	  level	  performance	  relative	  to	  filtered	  annotation	  based	  on	  the	  aligners	  STAR,	  TopHat2	  and	  GSNAP.	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Supplementary	  Figure	  30.	  Influence	  of	  different	  aligners	  on	  annotattion	  usage	  (D.	  melanogaster).	  See	  Supplementary	  Fig.	  29	  for	  details.	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Supplementary	  Figure	  31.	  Influence	  of	  different	  aligners	  on	  annotation	  usage	  (C.	  elegans).	  See	  Supplementary	  Fig.	  29	  for	  details.	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  Table	  1.	  Developer	  team	  submission	  details	  	  




Use	  of	  reference	  
annotation	  
Quantified	  features	   Multiple	  transcripts	  
reported	  per	  gene	  
H.	  sapiens	   	   	   	   	   	   	  
Iseli	   Tromer	  
fetchGWI,	  megablast,	  
SIBsim4	   yes	   no	   transcript	   yes	  
Gerstein	   Trembly	  all	   TopHat	   no	   no	   transcript	   yes	  
	  	   Trembly	  high	   TopHat	   no	   no	   transcript	   yes	  
Rätsch	   mGene	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mGene	  graph	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mTim	   PALMapper	   no	   no	   transcript	   yes	  
Richard	   Oases	   BLAT	   no	   no	   no	   yes	  
n.a.	   Cufflinks	   TopHat	   no	   no	   transcript	   yes	  
Stanke	   AUGUSTUS	  high	   BLAT	   yes	   no	   transcript	   yes	  
	  	   AUGUSTUS	  all	   BLAT	   yes	   no	   transcript	   yes	  
	  	   AUGUSTUS	  de-­‐novo	   n.a	   yes	   no	   transcript	   no	  
Searle	   Exonerate	  SM	  all	   Exonerate	   yes	   no	   no	   no	  
	  	   Exonerate	  SM	  high	   Exonerate	   yes	   no	   no	   no	  
Wu	   GSTRUCT	   GSNAP	   no	   no	   no	   no	  
Guigo	   Nextgeneid	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	  de-­‐novo	   GEM	   yes	   no	   no	   no	  
Solovyev	   Transomics	  all	   	  	   yes	   no	   transcript	   no	  
	  	   Transomics	  high	   	  	   yes	   no	   transcript	   no	  
Wold	   Velvet	   BLAT	   no	   no	   exon	   yes	  
	  	   Velvet	  AUGUSTUS	   BLAT	   no	   no	   exon	   yes	  
n.a	   iReckon	  full	   TopHat	   no	   yes	   transcript	   yes	  
	   iReckon	  ends	   TopHat	   no	   yes	   transcript	   yes	  
n.a	   SLIDE	  all	   TopHat	   no	   yes	   transcript	   yes	  
	  	   SLIDE	  high	   TopHat	   no	   yes	   transcript	   yes	  
D.	  melanogaster	   	   	   	   	   	   	  
	  Iseli	   Tromer	  
fetchGWI,	  megablast,	  
SIBsim4	   yes	   no	   transcript	   yes	  
	  Rätsch	   mGene	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mGene	  graph	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mTim	   PALMapper	   no	   no	   transcript	   yes	  
	  Richard	   Oases	   BLAT	   no	   no	   no	   yes	  
	  n.a.	   Cufflinks	   TopHat	   no	   no	   transcript	   yes	  
	  Stanke	   AUGUSTUS	  all	   BLAT	   yes	   no	   transcript	   yes	  
	  	   AUGUSTUS	  de-­‐novo	   n.a.	   yes	   no	   transcript	   no	  
	  Wu	   GSTRUCT	   GSNAP	   no	   no	   no	   no	  
	  Guigo	   Nextgeneid	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	  de-­‐novo	   GEM	   yes	   no	   no	   no	  
	  Solovyev	   Transomics	  all	   	  	   yes	   no	   transcript	   no	  
	  	   Transomics	  high	   	  	   yes	   no	   transcript	   no	  
	  Wold	   Velvet	   BLAT	   no	   no	   exon	   yes	  
	  n.a.	   iReckon	  full	   TopHat	   no	   yes	   transcript	   yes	  
	   iReckon	  ends	   TopHat	   no	   yes	   transcript	   yes	  
	  n.a.	   SLIDE	  all	   TopHat	   no	   yes	   transcript	   yes	  
	  	   SLIDE	  high	   TopHat	   no	   yes	   transcript	   yes	  
C.	  elegans	   	   	   	   	   	   	  
	  Iseli	   Tromer	  
fetchGWI,	  megablast,	  
SIBsim4	   yes	   no	   transcript	   yes	  
	  Rätsch	   mGene	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mGene	  graph	   PALMapper	   yes	   no	   transcript	   yes	  
	  	   mTim	   PALMapper	   no	   no	   transcript	   yes	  
	  Richard	   Oases	   BLAT	   no	   no	   no	   yes	  
	  n.a.	   Cufflinks	   TopHat	   no	   no	   transcript	   yes	  
	  Stanke	   AUGUSTUS	  high	   BLAT	   yes	   no	   transcript	   yes	  
	  	   AUGUSTUS	  all	   BLAT	   yes	   no	   transcript	   yes	  
	  	   AUGUSTUS	  de-­‐novo	   n.a.	   yes	   no	   transcript	   no	  
	  Searle	   Exonerate	  SM	  all	   Exonerate	   yes	   no	   no	   no	  
	  	   Exonerate	  SM	  high	   Exonerate	   yes	   no	   no	   no	  
	  Wu	   GSTRUCT	   GSNAP	   no	   no	   no	   no	  
	  Guigo	   Nextgeneid	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	   GEM	   yes	   no	   no	   no	  
	  	   NextgeneidAS	  de-­‐novo	   GEM	   yes	   no	   no	   no	  
	  Solovyev	   Transomics	  all	   	  	   yes	   no	   transcript	   no	  
	  	   Transomics	  high	   	  	   yes	   no	   transcript	   no	  
	  Wold	   Velvet	   BLAT	   no	   no	   exon	   yes	  
	  	   Velvet	  AUGUSTUS	   BLAT	   no	   no	   exon	   yes	  
	  n.a.	   iReckon	  full	   TopHat	   no	   yes	   transcript	   yes	  
	   iReckon	  ends	   TopHat	   no	   yes	   transcript	   yes	  
	  n.a.	   SLIDE	  all	   TopHat	   no	   yes	   transcript	   yes	  
	  	   SLIDE	  high	   TopHat	   no	   yes	   transcript	   yes	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Supplementary	  Table	  2.	  Nucleotide-­‐level	  performance	  	  
	   H.	  sapiens	   D.	  melanogaster	   C.	  elegans	  
	   Sensitivity	   Precision	   Sensitivity	   Precision	   Sensitivity	   Precision	  






96.88%	   65.28%	  
AUGUSTUS	  high	   63.70%	   84.75%	   	   	   96.65%	   72.32%	  
AUGUSTUS	  no	  RNA	   55.46%	   44.91%	   83.93%	   83.63%	   95.68%	   60.17%	  
Cufflinks	   79.31%	   59.98%	   84.98%	   90.87%	   88.61%	   75.81%	  
Exonerate	  all	   66.89%	   87.21%	   77.19%	   92.87%	   84.82%	   78.73%	  
Exonerate	  high	   65.01%	   90.33%	   75.22%	   94.54%	   83.78%	   80.12%	  
GSTRUCT	   60.59%	   86.08%	   58.13%	   88.91%	   76.67%	   69.75%	  
iReckon	  full	   78.33%	   31.29%	   89.72%	   77.56%	   96.08%	   83.42%	  
iReckon	  ends	   83.44%	   10.01%	   92.40%	   69.20%	   97.17%	   73.29%	  
mGene	   71.38%	   42.86%	   75.33%	   87.87%	   95.28%	   72.73%	  
mGene	  graph	   67.56%	   55.51%	   71.98%	   90.68%	   85.81%	   75.70%	  
mTim	   54.06%	   90.24%	   61.97%	   93.06%	   78.08%	   81.31%	  
NextGeneid	   64.73%	   80.59%	   80.36%	   94.22%	   84.51%	   79.16%	  
NextGeneidAS	   63.48%	   81.01%	   79.51%	   94.44%	   83.32%	   79.13%	  
NextGeneidAS	  ab-­‐initio	   62.95%	   79.72%	   79.32%	   94.37%	   83.26%	   79.32%	  
Oases	   68.28%	   68.53%	   75.98%	   91.65%	   76.58%	   80.52%	  
SLIDE	  all	   89.28%	   88.33%	   96.67%	   96.15%	   93.36%	   96.90%	  
SLIDE	  high	   76.48%	   87.87%	   91.94%	   96.64%	   88.41%	   97.07%	  
Transomics	  all	   45.65%	   53.57%	   68.35%	   83.70%	   98.36%	   72.00%	  
Transomics	  high	   45.29%	   75.06%	   68.30%	   88.99%	   98.12%	   82.61%	  
Trembly	  all	   70.54%	   85.99%	   	   	   	  	   	  	  
Trembly	  high	   53.24%	   91.41%	   	   	   	  	   	  	  
Tromer	   84.67%	   39.50%	   92.06%	   76.70%	   87.74%	   63.15%	  
Velvet	   65.79%	   78.69%	   72.54%	   88.07%	   77.73%	   82.18%	  
Velvet	  +	  AUGUSTUS	   37.66%	   75.51%	   	  	   	  	   65.72%	   76.78%	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Supplementary	  Table	  3.	  Exon-­‐,	  transcript-­‐	  and	  gene-­‐level	  performance	  for	  CDS	  reconstruction	  	  	  
	   Exon	   Transcript	   Gene	  
	   Sensitivity	   Precision	   Sensitivity	   Precision	   Sensitivity	   Precision	  
H.	  sapiens	   	   	   	   	   	   	  
AUGUSTUS	  all	   66.18%	   75.03%	   19.51%	   43.70%	   61.47%	   45.64%	  
AUGUSTUS	  high	   66.09%	   81.46%	   19.50%	   49.45%	   61.46%	   53.23%	  
AUGUSTUS	  no	  RNA	   54.96%	   48.88%	   5.34%	   9.28%	   17.61%	   9.28%	  
Exonerate	  all	   57.36%	   85.11%	   19.77%	   31.88%	   58.12%	   31.88%	  
Exonerate	  high	   56.04%	   89.39%	   16.24%	   42.65%	   54.29%	   42.65%	  
mGene	   63.13%	   50.32%	   14.62%	   10.01%	   50.01%	   10.02%	  
mGene	  graph	   53.49%	   82.44%	   16.03%	   34.44%	   49.33%	   46.01%	  
mTim	   28.76%	   92.55%	   8.82%	   46.66%	   27.52%	   52.53%	  
NextGeneid	   50.47%	   85.22%	   11.29%	   38.01%	   40.96%	   38.01%	  
NextGeneidAS	   50.11%	   82.48%	   11.77%	   31.47%	   39.84%	   31.47%	  
NextGeneidAS	  ab-­‐initio	   50.14%	   80.49%	   11.76%	   29.20%	   39.82%	   29.20%	  
Transomics	  all	   66.23%	   50.68%	   11.10%	   14.59%	   39.52%	   14.59%	  
Transomics	  high	   65.58%	   69.73%	   11.10%	   23.89%	   39.51%	   23.89%	  
Tromer	   31.58%	   29.65%	   2.23%	   0.93%	   6.30%	   1.66%	  
D.	  melanogaster	   	   	   	   	   	   	  
AUGUSTUS	  all	   73.74%	   77.11%	   24.47%	   39.36%	   48.53%	   44.03%	  
AUGUSTUS	  no	  RNA	   64.97%	   70.15%	   16.60%	   34.09%	   33.18%	   34.09%	  
Exonerate	  all	   62.39%	   77.96%	   17.31%	   28.01%	   33.88%	   28.01%	  
Exonerate	  high	   60.48%	   81.96%	   16.34%	   39.36%	   32.63%	   39.36%	  
mGene	   70.73%	   81.30%	   22.00%	   44.02%	   43.99%	   44.02%	  
mGene	  graph	   62.54%	   82.58%	   19.34%	   41.26%	   38.43%	   47.14%	  
mTim	   35.55%	   82.59%	   8.90%	   34.06%	   17.66%	   40.08%	  
NextGeneid	   59.77%	   76.11%	   18.69%	   38.84%	   37.37%	   38.84%	  
NextGeneidAS	   61.43%	   73.08%	   19.20%	   32.29%	   37.92%	   32.29%	  
NextGeneidAS	  ab-­‐initio	   61.44%	   72.99%	   19.24%	   32.21%	   37.99%	   32.21%	  
Transomics	  all	   73.62%	   66.12%	   23.48%	   33.54%	   46.95%	   33.54%	  
Transomics	  high	   73.56%	   71.22%	   23.48%	   37.72%	   46.93%	   37.72%	  
Tromer	   13.85%	   18.64%	   3.26%	   2.81%	   6.46%	   5.75%	  
C.	  elegans	   	   	   	   	   	   	  
AUGUSTUS	  all	   84.38%	   72.19%	   48.20%	   36.02%	   60.15%	   38.76%	  
AUGUSTUS	  high	   84.21%	   79.22%	   48.13%	   42.44%	   60.06%	   45.98%	  
AUGUSTUS	  no	  RNA	   78.94%	   64.66%	   36.28%	   27.20%	   45.52%	   27.20%	  
Exonerate	  all	   67.67%	   82.06%	   34.18%	   32.66%	   42.46%	   32.66%	  
Exonerate	  high	   66.55%	   84.82%	   32.55%	   41.25%	   40.84%	   41.25%	  
mGene	   83.62%	   74.15%	   45.48%	   41.94%	   57.05%	   41.94%	  
mGene	  graph	   72.62%	   77.61%	   45.02%	   45.46%	   56.38%	   47.01%	  
mTim	   45.34%	   85.51%	   20.24%	   36.66%	   25.24%	   43.02%	  
NextGeneid	   70.15%	   81.18%	   30.28%	   39.80%	   37.98%	   39.80%	  
NextGeneidAS	   69.78%	   79.51%	   30.39%	   33.37%	   37.96%	   33.37%	  
NextGeneidAS	  ab-­‐initio	   69.78%	   79.43%	   30.39%	   33.26%	   37.97%	   33.26%	  
Transomics	  all	   86.37%	   65.43%	   48.30%	   32.82%	   60.56%	   32.82%	  
Transomics	  high	   86.10%	   74.75%	   48.28%	   40.33%	   60.54%	   40.33%	  
Tromer	   20.85%	   26.55%	   1.20%	   0.51%	   1.50%	   1.11%	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Supplementary	  Table	  4.	  Exon-­‐,	  transcript-­‐	  and	  gene-­‐level	  performance	  (fixed	  evaluation	  mode)	  	  
	   Exon	   Transcript	   Gene	  
	   Sensitivity	   Precision	   Sensitivity	   Precision	   Sensitivity	   Precision	  
H.	  sapiens	   	   	   	   	   	   	  
AUGUSTUS	  all	   49.07%	   64.29%	   0.00%	   0.00%	   0.01%	   0.01%	  
AUGUSTUS	  high	   49.00%	   69.85%	   0.00%	   0.01%	   0.01%	   0.01%	  
AUGUSTUS	  no	  RNA	   41.27%	   42.41%	   0.00%	   0.00%	   0.00%	   0.00%	  
Cufflinks	   42.63%	   62.90%	   0.00%	   0.00%	   0.01%	   0.00%	  
Exonerate	  all	   43.32%	   71.18%	   0.00%	   0.00%	   0.01%	   0.00%	  
Exonerate	  high	   42.75%	   75.85%	   0.00%	   0.01%	   0.01%	   0.01%	  
GSTRUCT	   41.58%	   79.67%	   0.00%	   0.00%	   0.00%	   0.00%	  
iReckon	  full	   48.48%	   68.40%	   0.06%	   0.06%	   0.24%	   0.06%	  
iReckon	  ends	   50.26%	   64.32%	   0.05%	   0.03%	   0.18%	   0.03%	  
mGene	   47.14%	   41.63%	   0.00%	   0.00%	   0.01%	   0.00%	  
mGene	  graph	   46.52%	   59.98%	   0.00%	   0.01%	   0.02%	   0.01%	  
mTim	   38.28%	   73.72%	   0.00%	   0.00%	   0.01%	   0.01%	  
NextGeneid	   39.79%	   73.26%	   0.01%	   0.12%	   0.02%	   0.12%	  
NextGeneidAS	   38.94%	   69.02%	   0.00%	   0.09%	   0.02%	   0.09%	  
NextGeneidAS	  ab-­‐initio	   38.97%	   67.58%	   0.00%	   0.14%	   0.02%	   0.14%	  
Oases	   36.00%	   29.91%	   0.00%	   0.00%	   0.01%	   0.00%	  
SLIDE	  all	   52.62%	   79.66%	   3.13%	   4.75%	   12.03%	   18.18%	  
SLIDE	  high	   38.56%	   84.06%	   3.82%	   11.53%	   14.75%	   18.76%	  
Transomics	  all	   48.52%	   45.72%	   0.05%	   0.63%	   0.19%	   0.63%	  
Transomics	  high	   48.01%	   62.85%	   0.05%	   1.02%	   0.19%	   1.02%	  
Trembly	  all	   43.14%	   65.35%	   0.01%	   0.01%	   0.02%	   0.01%	  
Trembly	  high	   38.76%	   74.96%	   0.00%	   0.00%	   0.01%	   0.01%	  
Tromer	   23.87%	   21.04%	   0.00%	   0.00%	   0.00%	   0.00%	  
Velvet	   36.28%	   46.45%	   0.00%	   0.00%	   0.00%	   0.00%	  
Velvet	  +	  AUGUSTUS	   22.57%	   73.75%	   0.00%	   0.00%	   0.00%	   0.00%	  
D.	  melanogaster	   	   	   	   	   	   	  
AUGUSTUS	  all	   45.45%	   51.16%	   0.01%	   0.02%	   0.03%	   0.02%	  
AUGUSTUS	  no	  RNA	   40.06%	   47.22%	   0.00%	   0.01%	   0.01%	   0.01%	  
Cufflinks	   39.06%	   49.65%	   0.00%	   0.01%	   0.01%	   0.01%	  
Exonerate	  all	   40.32%	   51.70%	   0.02%	   0.03%	   0.04%	   0.03%	  
Exonerate	  high	   39.52%	   57.66%	   0.02%	   0.04%	   0.03%	   0.04%	  
GSTRUCT	   33.34%	   59.03%	   0.00%	   0.01%	   0.01%	   0.01%	  
iReckon	  full	   61.82%	   61.71%	   0.03%	   0.03%	   0.05%	   0.03%	  
iReckon	  ends	   58.56%	   59.42%	   0.02%	   0.02%	   0.04%	   0.02%	  
mGene	   42.61%	   55.60%	   0.03%	   0.05%	   0.05%	   0.05%	  
mGene	  graph	   40.36%	   54.37%	   0.03%	   0.05%	   0.05%	   0.05%	  
mTim	   33.87%	   55.67%	   0.01%	   0.02%	   0.02%	   0.03%	  
NextGeneid	   37.49%	   51.53%	   0.01%	   0.02%	   0.03%	   0.02%	  
NextGeneidAS	   38.88%	   47.37%	   0.02%	   0.02%	   0.03%	   0.02%	  
NextGeneidAS	  ab-­‐initio	   38.88%	   47.33%	   0.03%	   0.03%	   0.04%	   0.03%	  
Oases	   33.61%	   28.54%	   0.01%	   0.01%	   0.03%	   0.01%	  
SLIDE	  all	   84.78%	   94.14%	   44.19%	   25.52%	   76.99%	   70.36%	  
SLIDE	  high	   77.01%	   95.78%	   44.75%	   50.81%	   82.73%	   75.38%	  
Transomics	  all	   41.16%	   44.40%	   0.44%	   0.65%	   0.88%	   0.65%	  
Transomics	  high	   41.09%	   47.77%	   0.44%	   0.73%	   0.88%	   0.73%	  
Tromer	   10.46%	   10.56%	   0.00%	   0.00%	   0.00%	   0.00%	  
Velvet	   30.27%	   32.91%	   0.02%	   0.02%	   0.03%	   0.02%	  
C.	  elegans	   	   	   	   	   	   	  
AUGUSTUS	  all	   62.92%	   53.19%	   0.00%	   0.00%	   0.00%	   0.00%	  
AUGUSTUS	  high	   62.80%	   58.34%	   0.00%	   0.00%	   0.00%	   0.00%	  
AUGUSTUS	  no	  RNA	   59.53%	   47.94%	   0.00%	   0.00%	   0.00%	   0.00%	  
Cufflinks	   53.55%	   59.41%	   0.00%	   0.00%	   0.00%	   0.00%	  
Exonerate	  all	   53.51%	   60.84%	   0.00%	   0.00%	   0.00%	   0.00%	  
Exonerate	  high	   53.01%	   63.98%	   0.00%	   0.00%	   0.00%	   0.00%	  
GSTRUCT	   49.19%	   64.98%	   0.00%	   0.00%	   0.00%	   0.00%	  
iReckon	  full	   78.70%	   71.81%	   0.00%	   0.00%	   0.00%	   0.00%	  
iReckon	  ends	   71.85%	   69.63%	   0.00%	   0.00%	   0.00%	   0.00%	  
mGene	   62.93%	   55.35%	   0.00%	   0.00%	   0.00%	   0.00%	  
mGene	  graph	   56.22%	   56.33%	   0.00%	   0.00%	   0.00%	   0.00%	  
mTim	   52.80%	   62.77%	   0.00%	   0.00%	   0.00%	   0.00%	  
NextGeneid	   59.65%	   67.18%	   4.16%	   5.03%	   5.22%	   5.03%	  
NextGeneidAS	   59.67%	   64.82%	   4.58%	   4.21%	   5.66%	   4.21%	  
NextGeneidAS	  ab-­‐initio	   59.74%	   64.92%	   4.63%	   4.28%	   5.73%	   4.28%	  
Oases	   45.33%	   42.17%	   0.00%	   0.00%	   0.00%	   0.00%	  
SLIDE	  all	   87.50%	   97.24%	   40.85%	   12.66%	   50.26%	   43.98%	  
SLIDE	  high	   81.65%	   97.94%	   56.51%	   50.52%	   70.19%	   61.42%	  
Transomics	  all	   88.87%	   67.32%	   54.36%	   36.94%	   68.16%	   36.94%	  
Transomics	  high	   88.45%	   76.78%	   54.35%	   45.40%	   68.14%	   45.40%	  
Tromer	   22.72%	   19.22%	   0.00%	   0.00%	   0.00%	   0.00%	  
Velvet	   45.87%	   50.48%	   0.00%	   0.00%	   0.00%	   0.00%	  
Velvet	  +	  AUGUSTUS	   58.49%	   67.24%	   0.00%	   0.00%	   0.00%	   0.00%	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Supplementary	  Table	  5.	  Exon-­‐,	  transcript-­‐	  and	  gene-­‐level	  performance	  (flexible	  evalutation	  mode)	  	  
	   Exon	   Transcript	   Gene	  
	   Sensitivity	   Precision	   Sensitivity	   Precision	   Sensitivity	   Precision	  
H.	  sapiens	   	   	   	   	   	   	  
AUGUSTUS	  all	   81.16%	   77.47%	   16.27%	   39.26%	   56.16%	   42.71%	  
AUGUSTUS	  high	   81.05%	   84.15%	   16.27%	   44.41%	   56.16%	   49.78%	  
AUGUSTUS	  no	  RNA	   65.55%	   50.73%	   3.52%	   8.03%	   13.38%	   8.03%	  
Cufflinks	   73.45%	   79.57%	   16.03%	   19.29%	   53.55%	   20.36%	  
Exonerate	  all	   74.59%	   88.34%	   17.22%	   28.60%	   55.53%	   28.60%	  
Exonerate	  high	   72.72%	   92.46%	   13.23%	   41.92%	   50.28%	   41.92%	  
GSTRUCT	   70.63%	   96.42%	   14.10%	   59.85%	   54.02%	   59.85%	  
iReckon	  full	   67.78%	   83.05%	   31.80%	   38.87%	   73.63%	   38.87%	  
iReckon	  ends	   73.24%	   83.26%	   27.78%	   35.77%	   71.61%	   35.77%	  
mGene	   78.40%	   50.96%	   10.83%	   8.98%	   41.35%	   9.00%	  
mGene	  graph	   77.27%	   73.14%	   14.90%	   14.89%	   48.17%	   21.42%	  
mTim	   64.86%	   90.42%	   10.14%	   22.66%	   35.78%	   36.95%	  
NextGeneid	   67.36%	   89.58%	   11.30%	   36.99%	   43.27%	   36.99%	  
NextGeneidAS	   66.65%	   87.32%	   11.96%	   27.73%	   42.73%	   27.73%	  
NextGeneidAS	  ab-­‐initio	   66.68%	   85.56%	   11.94%	   26.60%	   42.63%	   26.60%	  
Oases	   62.02%	   40.55%	   10.04%	   5.11%	   34.05%	   4.74%	  
SLIDE	  all	   72.58%	   84.10%	   8.78%	   12.68%	   29.08%	   34.60%	  
SLIDE	  high	   54.75%	   88.22%	   8.65%	   22.66%	   31.09%	   31.62%	  
Transomics	  all	   76.84%	   54.35%	   8.41%	   13.28%	   32.16%	   13.28%	  
Transomics	  high	   76.14%	   74.64%	   8.41%	   21.74%	   32.16%	   21.74%	  
Trembly	  all	   75.45%	   83.44%	   21.82%	   22.73%	   60.53%	   38.37%	  
Trembly	  high	   64.30%	   90.24%	   12.84%	   30.28%	   43.60%	   41.80%	  
Tromer	   49.02%	   37.22%	   4.27%	   3.70%	   13.92%	   6.48%	  
Velvet	   62.05%	   59.56%	   5.57%	   6.81%	   21.35%	   7.26%	  
Velvet	  +	  AUGUSTUS	   38.97%	   90.68%	   7.17%	   45.22%	   27.44%	   45.35%	  
D.	  melanogaster	   	   	   	   	   	   	  
AUGUSTUS	  all	   82.61%	   86.03%	   42.66%	   61.14%	   73.03%	   65.92%	  
AUGUSTUS	  no	  RNA	   71.12%	   77.83%	   23.30%	   42.22%	   41.21%	   42.22%	  
Cufflinks	   71.73%	   83.70%	   36.18%	   46.32%	   56.37%	   50.06%	  
Exonerate	  all	   73.32%	   86.35%	   38.51%	   51.44%	   58.83%	   51.44%	  
Exonerate	  high	   69.54%	   92.50%	   30.98%	   66.02%	   54.54%	   66.02%	  
GSTRUCT	   59.66%	   95.60%	   28.21%	   76.77%	   49.10%	   76.77%	  
iReckon	  full	   85.85%	   82.43%	   65.22%	   57.94%	   89.07%	   57.94%	  
iReckon	  ends	   82.93%	   80.44%	   57.05%	   51.13%	   83.09%	   51.13%	  
mGene	   75.49%	   91.06%	   38.02%	   67.02%	   67.17%	   67.05%	  
mGene	  graph	   73.03%	   90.92%	   40.00%	   64.82%	   67.78%	   70.56%	  
mTim	   62.35%	   90.40%	   20.59%	   40.70%	   34.09%	   53.27%	  
NextGeneid	   70.53%	   89.19%	   36.30%	   62.23%	   64.27%	   62.23%	  
NextGeneidAS	   73.97%	   83.76%	   40.05%	   49.64%	   66.30%	   49.64%	  
NextGeneidAS	  ab-­‐initio	   73.95%	   83.66%	   40.05%	   49.61%	   66.25%	   49.61%	  
Oases	   64.31%	   51.05%	   33.99%	   18.61%	   55.47%	   25.39%	  
SLIDE	  all	   89.08%	   95.36%	   52.80%	   31.26%	   82.02%	   74.88%	  
SLIDE	  high	   82.31%	   96.83%	   53.22%	   58.60%	   88.50%	   80.58%	  
Transomics	  all	   73.74%	   74.03%	   35.11%	   44.78%	   62.71%	   44.78%	  
Transomics	  high	   73.63%	   79.67%	   35.11%	   50.38%	   62.69%	   50.38%	  
Tromer	   29.15%	   27.41%	   9.37%	   4.79%	   15.69%	   10.47%	  
Velvet	   58.59%	   58.75%	   24.09%	   22.63%	   42.39%	   24.81%	  
C.	  elegans	   	   	   	   	   	   	  
AUGUSTUS	  all	   91.76%	   76.26%	   59.28%	   44.09%	   72.35%	   46.62%	  
AUGUSTUS	  high	   91.48%	   83.55%	   59.21%	   51.96%	   72.26%	   55.33%	  
AUGUSTUS	  no	  RNA	   86.51%	   68.56%	   42.25%	   31.53%	   52.77%	   31.53%	  
Cufflinks	   78.38%	   84.84%	   39.75%	   37.53%	   48.04%	   42.88%	  
Exonerate	  all	   76.99%	   85.55%	   43.82%	   40.02%	   52.90%	   40.02%	  
Exonerate	  high	   75.75%	   89.27%	   39.98%	   50.42%	   49.83%	   50.42%	  
GSTRUCT	   71.48%	   91.85%	   39.03%	   59.92%	   48.72%	   59.92%	  
iReckon	  full	   94.09%	   84.88%	   78.10%	   52.98%	   89.87%	   52.98%	  
iReckon	  ends	   87.39%	   83.71%	   68.45%	   44.85%	   79.25%	   44.85%	  
mGene	   90.99%	   78.64%	   55.27%	   50.73%	   69.01%	   50.73%	  
mGene	  graph	   83.26%	   81.96%	   55.78%	   54.68%	   68.88%	   56.18%	  
mTim	   77.16%	   88.48%	   31.86%	   37.72%	   38.96%	   46.54%	  
NextGeneid	   78.45%	   86.60%	   37.04%	   44.55%	   46.19%	   44.55%	  
NextGeneidAS	   77.91%	   82.80%	   38.45%	   35.17%	   46.71%	   35.17%	  
NextGeneidAS	  ab-­‐initio	   77.85%	   82.76%	   38.45%	   35.41%	   46.71%	   35.41%	  
Oases	   66.77%	   61.04%	   32.98%	   17.39%	   39.70%	   22.24%	  
SLIDE	  all	   88.52%	   97.34%	   42.85%	   13.34%	   51.92%	   45.44%	  
SLIDE	  high	   82.97%	   98.04%	   58.13%	   51.78%	   71.61%	   62.66%	  
Transomics	  all	   93.90%	   69.92%	   58.10%	   39.32%	   72.52%	   39.32%	  
Transomics	  high	   93.43%	   79.73%	   58.08%	   48.32%	   72.50%	   48.32%	  
Tromer	   39.43%	   32.92%	   7.24%	   1.96%	   8.97%	   4.96%	  
Velvet	   67.44%	   72.86%	   31.77%	   27.15%	   39.54%	   28.09%	  
Velvet	  +	  AUGUSTUS	   61.49%	   69.46%	   0.00%	   0.00%	   0.00%	   0.00%	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Supplementary	  Table	  6.	  Alternative	  splicing	  and	  transcript	  diversity	  	  
	   Minimum	   First	  quartile	   Median	   Mean	   Third	  quartile	   Maximum	  
H,	  sapiens	   	   	   	   	   	   	  CDS	  length	  (bp)	   1	   79	   115	   143.7	   159	   17330	  Exon	  length	  (bp)	   1	   87	   126	   224.9	   186	   91670	  Intron	  length	  (bp)	   3	   498	   1569	   6410	   4481	   4251000	  Exons	  per	  transcript	   1	   3	   5	   6.646	   8	   118	  Transcripts	  per	  gene	   1	   1	   1	   5.225	   7	   80	  
D.	  melanogaster	   	   	   	   	   	   	  CDS	  length	  (bp)	   1	   124	   197	   372.6	   402	   27710	  Exon	  length	  (bp)	   1	   144	   246	   476.2	   544	   28070	  Intron	  length	  (bp)	   4	   65	   104	   1540	   733	   139300	  Exons	  per	  transcript	   1	   2	   4	   5.496	   7	   78	  Transcripts	  per	  gene	   1	   1	   1	   1.943	   2	   31	  
C.	  elegans	   	   	   	   	   	   	  CDS	  length	  (bp)	   1	   99	   146	   205.3	   234	   14980	  Exon	  length	  (bp)	   1	   99	   146	   205.3	   234	   14980	  Intron	  length	  (bp)	   3	   50	   71	   330.6	   345	   21230	  Exons	  per	  transcript	   1	   4	   6	   6.819	   9	   66	  Transcripts	  per	  gene	   1	   1	   1	   1.255	   1	   15	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Supplementary	  Table	  7.	  NanoString	  probes	  and	  targeted	  transcript	  isoforms	  	  
Probe	  ID	   Targeted	  trancripts	  (Ensembl	  IDs)	   Probe	  sequence	  
adar1_sp1	   ENST00000292205,	  ENST00000494866,	  ENST00000368471	   ACTGGCAGTCTCCGGGTGTCCGGCCGTGTCCCGAGGAAGTGCAAGACCCGGGGTATTCC
CTCAGCGGATACTACACCCATCCATTTCAAGGCTATGAGCA	  
adar1_sp2	   ENST00000368474	   CGGCGGGTCGGGCCGGGCAATGCCTCGCGGGCGCAATGAATCCGCGGCAGGGGTATTC
CCTCAGCGGATACTACACCCATCCATTTCAAGGCTATGAGCA	  
atf2_common	   ENST00000264110,	  ENST00000345739,	  ENST00000392543,	  ENST00000392544,	  
ENST00000409499,	  ENST00000409833,	  ENST00000413123,	  ENST00000415955,	  
ENST00000417080,	  ENST00000421438,	  ENST00000426833,	  ENST00000428760,	  
ENST00000429579,	  ENST00000435231,	  ENST00000437522,	  ENST00000445349,	  








atf2_sp2	   ENST00000429579,	  ENST00000538946,	  ENST00000428760,	  ENST00000417080,	  
ENST00000421438,	  ENST00000409437,	  ENST00000392544,	  ENST00000264110,	  




ATP5J_common	   ENST00000284971,	  ENST00000400087,	  ENST00000400090,	  ENST00000400093,	  
ENST00000400094,	  ENST00000457143,	  ENST00000486002,	  ENST00000400099	  
CAGAGTATCAGCAAGAGCTGGAGAGGGAGCTTTTTAAGCTCAAGCAAATGTTTGGTAAT
GCAGACATGAATACATTTCCCACCTTCAAATTTGAA	  
Bcl11a_sp1	   ENST00000335712,	  ENST00000356842,	  ENST00000359629,	  ENST00000489516	   TTTATCAACGTCATCTAGAGGAATTTGCCCCAAACAGGAACACATAGCAGATAAACTTCT
GCACTGGAGGGGCCTCTCCTCCCCTCGTTCTGCACATGGA	  
Bcl11a_sp2	   ENST00000409351	   TATCAACGTCATCTAGAGGAATTTGCCCCAAACAGGAACACATAGCAGCTCAGACTGAAC
TGGAGGATGTATTTGTGTACCTTATGGTGT	  
BCL3	   ENST00000164227,	  ENST00000403534	   CGGAGCCTTACTGCCTTTGTACCCCACTCGGGCCATGGGCTCCCCGTTTCCTCTGGTGAAC
CTGCCTACACCCCTATACCCCATGATGTGCCCCATGGAA	  
BHLHB2	   ENST00000256495	   AAAAGCTTCAAAGTCTTGGTCTGTGAGTCACTCTTCAGTTTGGGAGCTGGGTCTGTGGCT
TTGATCAGAAGGTACTTTCAAAAGAGGGCTTTCCAGGGCT	  
Blnk_sp1_T	   ENST00000371176	   TGAAAACTATATTCATCCCACAGAAAGCAGTTCACCTCCACCTGAAAAAGGTCGAAACAG
TGGGGCCTGGGAAACCAAGTCACCTCCACCAGCTGCACCA	  
Blnk_sp2	   ENST00000413476,	  ENST00000224337,	  ENST00000427367,	  ENST00000467799	   TGAAAACTATATTCATCCCACAGAAAGCAGTTCACCTCCACCTGAAAAAGCTCCCATGGT
GAATAGATCAACCAAGCCAAATTCCTCAACGCCCGCCTCT	  
CARM1_sp1_T	   ENST00000592516,	  ENST00000344150	   TGTTATTGCCAGTGGCTCCAGCGTGGGCCACAACAACCTGATTCCTTTAGGGTCCTCCGG
CGCCCAGGGCAGTGGTGGTGGCAGCACGAGTGCCCACTAT	  
CD19	   ENST00000324662,	  ENST00000538922,	  ENST00000565089,	  ENST00000567541	   GAAGGTCTCAGCTGTGACTTTGGCTTATCTGATCTTCTGCCTGTGTTCCCTTGTGGGCATT
CTTCATCTTCAAAGAGCCCTGGTCCTGAGGAGGAAAAGA	  
Cd79b_sp1_T	   ENST00000349817	   TGAGCCAGTACCAGCAGCCAGATCGGAGGACCGGTACCGGAATCCCAAAGGATTCAGCA
CCTTGGCACAGCTGAAGCAGAGGAACACGCTGAAGGATGGT	  
Cd79b_sp2_T	   ENST00000559358,	  ENST00000006750,	  ENST00000392795	   CAACACCTCGGAGGTCTACCAGGGCTGCGGCACAGAGCTGCGAGTCATGGGATTCAGCA
CCTTGGCACAGCTGAAGCAGAGGAACACGCTGAAGGATGGT	  
cdkn1a_sp1_T	   ENST00000244741	   GAGCCGGAGCTGGGCGCGGATTCGCCGAGGCACCGAGGCACTCAGAGGAGGCGCCATG
TCAGAACCGGCTGGGGATGTCCGTCAGAACCCATGCGGCAGC	  
cdkn1a_sp2_T	   ENST00000405375,	  ENST00000478800	   GGATGCGTGTTCGCGGGTGTGTGCTGCGTTCACAGGTGTTTCTGCGGCAGGCGCCATGT
CAGAACCGGCTGGGGATGTCCGTCAGAACCCATGCGGCAGC	  
CEBPA	   ENST00000425420,	  ENST00000498907	   CTAGTATTTAGGATAACCTTGTGCCTTGGAAATGCAAACTCACCGCTCCAATGCCTACTGA
GTAGGGGGAGCAAATCGTGCCTTGTCATTTTATTTGGAG	  
CTCF_common	   ENST00000264010,	  ENST00000401394	   CCCAACGGAGACCTCACGCCCGAGATGATCCTCAGCATGATGGACCGGTGATGGCGGAG
CCTTGTGCGTCGCCAGGACTTCTCTGGGCTGTGTTTAAACG	  
CTCF_sp1	   ENST00000566078,	  ENST00000264010	   GAGCTGGGTTCTATTTTCCCTCCTCAAACTGACTTTGCAGCCACGGAGAGGCAGGGGAAA
TGGAAGGTGATGCAGTCGAAGCCATTGTGGAGGAGTCCGA	  
CTCFL_sp1	   ENST00000433949,	  ENST00000243914,	  ENST00000539382,	  ENST00000371196,	  
ENST00000426658,	  ENST00000423479,	  ENST00000422869,	  ENST00000502686	  
TGCCAGCAGAGATACCTACAAGCTGAAACGCCACATGAGAACGCACTCAGGTGAGAAGC
CTTACGAATGCCACATCTGCCACACCCGCTTCACCCAGAGC	  
CTCFL_sp2	   ENST00000429804	   TGCCAGCAGAGATACCTACAAGCTGAAACGCCACATGAGAACGCACTCAGGTGTGCATA
TGCGCAACTTGCATGCTTACAGCGCTGCAGAGCTGAAATGC	  
CTDSL_sp2_T	   ENST00000273179,	  ENST00000443503,	  ENST00000486978	   GCCCCAGTGTGCTTCCGCCACTGGTGGAGGAGAATGGTGGGCTTCAGAAGGGTGACCA
GAGGCAGGTCATTCCCATACCAAGTCCACCAGCTAAGTACCT	  
CTDSP1_common_T	   ENST00000273062,	  ENST00000428361,	  ENST00000443891,	  ENST00000452977,	  
ENST00000464255,	  ENST00000473420,	  ENST00000482272,	  ENST00000488627,	  
ENST00000491064,	  ENST00000497677,	  ENST00000498160	  
AGCTGACCTGCTGGACAAATGGGGGGCCTTCCGGGCCCGGCTGTTTCGAGAGTCCTGCG
TCTTCCACCGGGGGAACTACGTGAAGGACCTGAGCCGGTT	  
CTDSP2	   ENST00000398073	   CCTGTCCTGTACCGAGCTCTGTCTGTTCCAGCCTTCATCCTTCCTGGCTGTTGCTTTTCCTC
TTAAGGGCCTCAGAACTCTTGCTCTTCCTGGGCTGAGG	  
CTDSPL_sp1	   ENST00000443503	   GCCCCAGTGTGCTTCCGCCACTGGTGGAGGAGAATGGTGGGCTTCAGAAGCCACCAGCT
AAGTACCTTCTTCCAGAGGTGACGGTGCTTGACTATGGAAA	  
DES	   ENST00000492726,	  ENST00000477226,	  ENST00000373960	   GAGAACAATTTGGCTGCCTTCCGAGCGGACGTGGATGCAGCTACTCTAGCTCGCATTGAC
CTGGAGCGCAGAATTGAATCTCTCAACGAGGAGATCGCGT	  
DNMT1_common_T	   ENST00000340748,	  ENST00000359526,	  ENST00000540357,	  ENST00000586588,	  
ENST00000587197,	  ENST00000588913,	  ENST00000589294,	  ENST00000592705	  
CCTTTCCGGACCATCACGGTGCGAGACACGATGTCCGACCTGCCGGAGGTGCGGAATGG
AGCCTCGGCACTGGAGATCTCCTACAACGGGGAGCCTCAGT	  
E2F4	   ENST00000379378,	  ENST00000567007	   GTCAGAAATCTTTGATCCCACACGAGAGTGCATGAGCTCGGAGCTGCTGGAGGAGTTGA
TGTCCTCAGAAGTGTTTGCCCCTCTGCTTCGTCTTTCTCCA	  
E2F6_common	   ENST00000307236,	  ENST00000362009,	  ENST00000381525,	  ENST00000421117,	  
ENST00000428221,	  ENST00000437573,	  ENST00000444832,	  ENST00000455198,	  
ENST00000468775,	  ENST00000542100,	  ENST00000546212	  
AGGTTGCAACGAAACTGGGAGTCCGAAAGCGGAGAGTGTATGACATCACCAATGTCTTA
GATGGAATCGACCTCGTTGAAAAGAAATCCAAGAACCATAT	  




EGR1	   ENST00000239938	   CTTCAATGCTAGAAAATCGAGTTGGCAAAATGGGGTTTGGGCCCCTCAGAGCCCTGCCCT
GCACCCTTGTACAGTGTCTGTGCCATGGATTTCGTTTTTC	  
EOMES_common	   ENST00000295743,	  ENST00000449599,	  ENST00000537516	   CAACAAACTAGACATCAGTTCCTATGAATCTGAATATACTTCTAGCACATTGCTCCCATAT
GGCATTAAATCCTTGCCCCTTCAGACATCCCATGCCCTG	  
EP300	   ENST00000263253	   ACAAATATCCCTTTGGCTCCGTCCAGCGGTCAAGCTCCAGTGTCTCAAGCACAAATGTCTA
GTTCTTCCTGCCCGGTGAACTCTCCTATAATGCCTCCAG	  
esr1_common	   ENST00000206249,	  ENST00000338799,	  ENST00000406599,	  ENST00000427531,	  
ENST00000440973,	  ENST00000443427,	  ENST00000456483,	  ENST00000544394	  
GTAGAGGGCATGGTGGAGATCTTCGACATGCTGCTGGCTACATCATCTCGGTTCCGCATG
ATGAATCTGCAGGGAGAGGAGTTTGTGTGCCTCAAATCTA	  
esr2_sp1	   ENST00000353772,	  ENST00000554572,	  ENST00000344288,	  ENST00000358599	   ATGCGCCTGGCTAACCTCCTGATGCTCCTGTCCCACGTCAGGCATGCGAGGGCAGAAAA
GGCCTCTCAAACACTCACCTCATTTGGAATGAAGATGGAGA	  
esr2_sp2	   ENST00000554520,	  ENST00000341099,	  ENST00000267525,	  ENST00000555483	   ATGCGCCTGGCTAACCTCCTGATGCTCCTGTCCCACGTCAGGCATGCGAGTAACAAGGGC
ATGGAACATCTGCTCAACATGAAGTGCAAAAATGTGGTCC	  
ets1_common	   ENST00000319397,	  ENST00000345075,	  ENST00000526145,	  ENST00000530924,	  
ENST00000531611,	  ENST00000535549,	  ENST00000392668	  
CAGGAGATGGGGAAAGAGGAAAAACAAACCTAAGATGAATTATGAGAAACTGAGCCGT
GGCCTACGCTACTATTACGACAAAAACATCATCCACAAGACA	  




FOS	   ENST00000303562	   TCAAGTCCTTACCTCTTCCGGAGATGTAGCAAAACGCATGGAGTGTGTATTGTTCCCAGT
GACACTTCAGAGAGCTGGTAGTTAGTAGCATGTTGAGCCA	  
foxa2_body	   ENST00000319993,	  ENST00000377115,	  ENST00000419308	   CGTTCCGTCCCAAACAGAGGGCCACACAGATACCCCACGTTCTATATAAGGAGGAAAAC
GGGAAAGAATATAAAGTTAAAAAAAAGCCTCCGGTTTCCAC	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  trancripts	  (Ensembl	  IDs)	   Probe	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foxa2_sp2_T	   ENST00000377115	   CGGGTCCCTGGCGGCCGGTGTCTGAGGAGTCGGAGAGCCGAGGCGGCCAGACCGTGCG
CCCCGCGCTTCTCCCGAGGCCGTTCCGGGTCTGAACTGTAAC	  
FOXA3	   ENST00000302177	   CCCCGTGTTGGCCATGTCGTCACCATTCTCTCTGGCATGGGTTGGGTAGGGGATGGAGG
TGAGAATACTCCTTGGTTTTCTCTGAAGCCCACCCTTTCCC	  
gabpa_sp1_T	   ENST00000354828	   CCGGACGGGTCTAGGTGAGACAGAAGCCAAACAGGAGGAGGAAGTGGAGGGACTGAT
CCTTTGAAATACTCCAGCCATGACTAAAAGAGAAGCAGAGGAG	  
gabpa_sp2_T	   ENST00000400075	   CAGCCGGCTCTGGAGTGCGGGCGGGGGCGACAGGGCCGATTCCGGAGTGGGACTGATC
CTTTGAAATACTCCAGCCATGACTAAAAGAGAAGCAGAGGAG	  
GATA1_T	   ENST00000376665,	  ENST00000376670	   GTGTCCCACCCGCGAGGACTCTCCTCCCCAGGCCGTGGAAGATCTGGATGGAAAAGGCA
GCACCAGCTTCCTGGAGACTTTGAAGACAGAGCGGCTGAGC	  
HDAC1	   ENST00000373548,	  ENST00000476391	   CTGTTTTCGTACCTTCCCACTGGCCTCAAGTGAGCCAAGAAACACTGCCTGCCCTCTGTCT
GTCTTCTCCTAATTCTGCAGGTGGAGGTTGCTAGTCTAG	  
HDAC3_sp1	   ENST00000305264,	  ENST00000495485,	  ENST00000523353	   CATTGACCCATAGCCTGGTCCTGCATTACGGTCTCTATAAGAAGATGATCGTCTTCAAGCC
ATACCAGGCCTCCCAACATGACATGTGCCGCTTCCACTC	  
HDAC4	   ENST00000345617	   TGTCAGCTCACTCCAGCTTCACAAATGTGCTGAGAGCATTACTGTGTAGCCTTTTCTTTGA
AGACACACTCGGCTCTTCTCCACAGCAAGCGTCCAGGGC	  
HDAC5	   ENST00000225983,	  ENST00000336057,	  ENST00000393622	   CAGGGGAGGATCTGGAGGATCCACTACTGTCTTTAAGATGCAGAGTGGAGGGGAGGTG
GGCACCCACCCTGCGATTCTCCACCCTTTCCCCTTCTTTCGT	  




HNF1A	   ENST00000257555,	  ENST00000400024,	  ENST00000402929,	  ENST00000538646,	  




HNF1B	   ENST00000561193,	  ENST00000225893	   GTTTCCATCTGCAATGGTGGTCACAGATACCAGCAGCATCAGTACACTCACCAACATGTC
TTCAAGTAAACAGTGTCCTCTACAAGCCTGGTGATGCCCA	  
Hnf4g_common_T	   ENST00000396423	   AGAAAATAGTTATCCATTGACTAGAAATTAGTACATGCCCACAGCTGGCTCCCACGGTAG
CCAGGAGAATTATCTATAGGTGGAAAGTCTGTGTCAGCCA	  
HSF1	   ENST00000400780,	  ENST00000528838,	  ENST00000528988,	  ENST00000533240	   TGTTCGACCAGGGCCAGTTTGCCAAGGAGGTGCTGCCCAAGTACTTCAAGCACAACAAC
ATGGCCAGCTTCGTGCGGCAGCTCAACATGTATGGCTTCCG	  
IGF1R_common_T	   ENST00000268035,	  ENST00000558762	   GCGATTGCTGGGTGTGGTGTCCCAAGGCCAGCCAACACTGGTCATCATGGAACTGATGA
CACGGGGCGATCTCAAAAGTTATCTCCGGTCTCTGAGGCCA	  
IKZF1_common	   ENST00000331340,	  ENST00000343574,	  ENST00000346667,	  ENST00000349824,	  




IKZF1_sp1_T	   ENST00000357364,	  ENST00000331340,	  ENST00000343574,	  ENST00000413698,	  
ENST00000346667,	  ENST00000349824,	  ENST00000440768,	  ENST00000359197	  
CGAGGATCAGTCTTGGCCCCAAAGCGCGACGCACAAATCCACATAACCTGAGGACCATG
GATGCTGATGAGGGTCAAGACATGTCCCAAGTT	  
IKZF1_sp2	   ENST00000438033,	  ENST00000492782,	  ENST00000462201,	  ENST00000439701	   GTGTGGAAAAGGCAGCTCTCACTTGGCCTTGGCGAGGCCTCGGTTGGTTGATAACCTGA
GGACCATGGATGCTGATGAGGGTCAAGACATGTCCCAAGTT	  




IKZF3_sp2	   ENST00000583368,	  ENST00000293068,	  ENST00000348427	   TCACTGACCACAGCAGGTACCCCAGGCAAGAATCTGAGCAGTTATAACAGCAAGTGCGG
AGGCAAGACACATCAAAGCAGAGATGGGAAGTGAAAGAGCT	  




IL6receptor_common	   ENST00000344086,	  ENST00000368485	   TCCAATATTCGCTGTGTCAGCATAGAAGTAACTTACTTAGGTGTGGGGGAAGCACCATAA
CTTTGTTTAGCCCAAAACCAAGTCAAGTGAAAAAGGAGGA	  
IL8	   ENST00000307407,	  ENST00000483500,	  ENST00000401931	   GGAAGGAACCATCTCACTGTGTGTAAACATGACTTCCAAGCTGGCCGTGGCTCTCTTGGC
AGCCTTCCTGATTTCTGCAGCTCTGTGTGAAGGTGCAGTT	  
IL8RA	   ENST00000295683	   GTCCATTGGGCAGGCAGATGTTCCTAATAAAGCTTCTGTTCCGTGCTTGTCCCTGTGGAA
GTATCTTGGTTGTGACAGAGTCAAGGGTGTGTGCAGCATT	  
IL8RB	   ENST00000318507	   GATAGACAAATCTCCACCTTCAGACTGGTAGGCTCCTCCAGAAGCCATCAGACAGGAAG
ATGTGAAAATCCCCAGCACTCATCCCAGAATCACTAAGTGG	  
IRF8	   ENST00000268638,	  ENST00000566369	   CCCTCTGTCTGGGGTGGGATGCCTTACTTTGCACTTAATTTAATAAGGGCATTCTCGGAG
GAGTAGACGTTTAATACGAAGTGGCGGCATAGCCCTGCCG	  
JUND	   ENST00000252818	   TGCTACGAGTCCACATTCCTGTTTGTAATCCTTGGTTCGCCCGGTTTTCTGTTTTCAGTAAA
GTCTCGTTACGCCAGCTCGGCAAAAAAAAAAAAAAAAA	  
KAISO_sp1_T	   ENST00000326624	   CCAGCCTTCCGCGCGTCCGGAGGAGGAGAAGCGGCGGCGCCGGGAAGCAGGCATGGA
GAGTAGAAAACTGATTTCTGCTACAGACATTCAGTACTCTGGC	  
KAP1_common_T	   ENST00000253024,	  ENST00000341753	   CAGGCCGAGTGCAAACAGGGCAGCAGGCGGGGCTCCCTCTCGGGTCGCAGGCGCTCTCT
GCACACGCCGCAGTGCTCCAGCAGCTCCAGCGCCTCGGCGC	  
KLF4	   ENST00000374672,	  ENST00000493306,	  ENST00000497048	   CCGAGCATTTTCCAGGTCGGACCACCTCGCCTTACACATGAAGAGGCATTTTTAAATCCCA
GACAGTGGATATGACCCACACTGCCAGAAGAGAATTCAG	  
LEF1_sp1	   ENST00000509428,	  ENST00000438313,	  ENST00000505379,	  ENST00000510624,	  
ENST00000504775,	  ENST00000510135,	  ENST00000379951	  
TATCCCTTGTCTCCGGGTGGTGTTGGACAGATCACCCCACCTCTTGGCTGGTTTTCCCATC
ATATGATTCCCGGTCCTCCTGGTCCCCACACAACTGGCA	  




LIN28_common	   ENST00000254231,	  ENST00000326279	   GTCTGGAATCCATCCGTGTCACCGGACCTGGTGGAGTATTCTGTATTGGGAGTGAGAGG
CGGCCAAAAGGAAAGAGCATGCAGAAGCGCAGATCAAAAGG	  
MAX_sp1	   ENST00000556443,	  ENST00000358664,	  ENST00000358402,	  ENST00000553928,	  
ENST00000555667,	  ENST00000394606,	  ENST00000284165,	  ENST00000553951,	  
ENST00000556979,	  ENST00000556892,	  ENST00000557746,	  ENST00000557277	  
ACAGCTTTCACAGTTTGCGGGACTCAGTCCCATCACTCCAAGGAGAGAAGGCATCCCGG
GCCCAAATCCTAGACAAAGCCACAGAATATATCCAGTATAT	  
mef2a_common_T	   ENST00000354410,	  ENST00000449277,	  ENST00000557785,	  ENST00000557942,	  
ENST00000558812,	  ENST00000561125,	  ENST00000338042,	  ENST00000453228	  
CCCGCAGCCCCAGCCCCGACAGGAAATGGGGCGCTCCCCTGTGGACAGTCTGAGCAGCT
CTAGTAGCTCCTATGATGGCAGTGATCGGGAGGATCCACGG	  




mef2a_sp4	   ENST00000354410	   AAAAAATTAATGAGGAATTTGATAATATGATGCGGAATCATAAAATCGCACCTGGTCTGC
CACCTCAGAACTTTTCAATGTCTGTCACAGTTCCAGTGAC	  
mef2b_sp10_T	   ENST00000477565	   CCCCACTGCCACTCCCAGCTGCAAGGACCGTCTCTCAGCTGCGCTGGGAACCGCTGCTTC
TCGCTTATTAGAAAACTGTCTCTTTCCTTTTGTCCTGGT	  
mef2b_sp11_T	   ENST00000585679,	  ENST00000514819,	  ENST00000462498,	  ENST00000444486	   GTCGCTATGGAGGAGCCGGAGATGCAGCTCAAGGGGAAGAAAGCGCCGTGAAGAACCT
GGTGGACAGCAGCGTCTACTTCCGCAGCGTGGAGG	  
mef2b_sp12	   ENST00000591398,	  ENST00000162023,	  ENST00000494489,	  ENST00000462790,	  
ENST00000588208,	  ENST00000488252,	  ENST00000354191,	  ENST00000477565	  
TGGGAGGAGCAGAGCCAGGGAGCCATCTACACTGTGGAGTACGCCTGCAGCGCCGTGA
AGAACCTGGTGGACAGCAGCGTCTACTTCCGCAGCGTGGAGG	  
mef2b_sp7_T	   ENST00000410050,	  ENST00000424583,	  ENST00000409224	   CAGCCGCCGCGGGTCCGTGCGCCCAGCGTCCCAGGGCCCAGGCCGAGCAGACAAAGAT
CATTCCACTCAGCCTGGGACGATGGGGAGGAAAAAAATCCAG	  
mef2c_sp1	   ENST00000508569,	  ENST00000514015,	  ENST00000510942,	  ENST00000514028,	  
ENST00000437473,	  ENST00000504921,	  ENST00000503554,	  ENST00000506554	  
GGAAAATTAACGAAGATATTGATCTAATGATCAGCAGGCAAAGATTGTGTGCTGTTCCAC
CTCCCAACTTCGAGATGCCAGTCTCCATCCCAGTGTCCAG	  
mef2c_sp3	   ENST00000424173,	  ENST00000340208	   GAAGTAAAGAACGGAAGGCAAATGATTGTGGCAGTAAAGAAGTGTATGTGCAGGAACG
AATGCAGGAATTTGGGAACTGAGCTGTGCAAGTGCTGAAGAA	  




mef2d_sp4	   ENST00000454816,	  ENST00000360595,	  ENST00000368240	   CCTGCGAGTCATCACTTCCCAGGCAGGAAAGGGGTTAATGCATCACTTGACTGAGGACC
ATTTAGATCTGAACAATGCCCAGCGCCTTGGGGTCTCCCA	  
MYC	   ENST00000377970,	  ENST00000524013	   AGGAGCAAAAGCTCATTTCTGAAGAGGACTTGTTGCGGAAACGACGAGAACAGTTGAAA
CACAAACTTGAACAGCTACGGAACTCTTGTGCGTAAGGAAA	  
MYF5	   ENST00000228644	   TGGATTGCTTATCCAACATAGTGGACCGGATCACCTCCTCAGAGCAACCTGGGTTGCCTC
TCCAGGATCTGGCTTCTCTCTCTCCAGTTGCCAGCACCGA	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MYF6	   ENST00000228641	   GGAGGAGCAAGTATTGATTCGTCAGCCTCGAGTAGCCTTCGATGCCTTTCTTCCATCGTG
GACAGTATTTCCTCGGAGGAACGCAAACTCCCCTGCGTGG	  
MYOD1	   ENST00000250003	   GCATGGTGTGTGGTGCTACAGGGAATTTGTACGTTTATACCGCAGGCGGGCGAGCCGCG
GGCGCTCGCTCAGGTGATCAAAATAAAGGCGCTAATTTATA	  
NANOG	   ENST00000229307,	  ENST00000526286,	  ENST00000526434,	  ENST00000541267	   CTTCACCTATGCCTGTGATTTGTGGGCCTGAAGAAAACTATCCATCCTTGCAAATGTCTTC
TGCTGAGATGCCTCACACGGAGACTGTCTCTCCTCTTCC	  








NOTCH1	   ENST00000277541	   GAGGGCTTCAGCGGTCCCAACTGCCAGACCAACATCAACGAGTGTGCGTCCAACCCATG
TCTGAACCAGGGCACGTGTATTGACGACGTTGCCGGGTACA	  
NR2F2_sp2_T	   ENST00000394166	   CCAGTACTGCCGCCTCAAAAAGTGCCTCAAAGTGGGCATGAGACGGGAAGCGGTGCAG
AGGGGCAGGATGCCGCCGACCCAGCCGACCCACGGGCAGTTC	  




ONECUT1	   ENST00000305901	   CTTGGCAAGACAAATGATGAGCAGGAAAACACCACTGGATCTCACACCTTCAATCCATGA
CCATCCTCGCTGTGCTTGGCTGTTTAGTGGTTTGGAGCAT	  
ONECUT2	   ENST00000262095,	  ENST00000491143	   CCCAAACCAAAATGCTTGACATAAAGCCAAATCAACTGCCAAGCACACTTTATTTTGCATA
GGAGTATGCAGCCTAGGGAACCTTGGTTGAAAAGCAGCA	  
pbx1_common	   ENST00000367897,	  ENST00000420696,	  ENST00000465089,	  ENST00000468104,	  
ENST00000496120,	  ENST00000560469,	  ENST00000560641	  
TTTCTCTCCCAACGCTGAAGCGGTCAGACTGGAGGTCGAAGCAATCAGCAAACACAATAA
GAGTCTCCTTCTCTTCTCTTCTTTGGGATGCTATTTCAGC	  
pbx3_sp1	   ENST00000373483,	  ENST00000373482,	  ENST00000373492	   AATGAAACCAGCGCTCTTCAGCGTCCTGTGTGAGATCAAAGAGAAAACAGGCATGTAAT
GAATTTACTACACATGTGATGAACCTTCTCCGAGAACAGAG	  








POLR2A	   ENST00000322644	   TTCTACTCCAACATTCAGACTGTCATTAACAACTGGCTCCTCATCGAGGGTCATACTATTG
GCATTGGGGACTCCATTGCTGATTCTAAGACTTACCAGG	  




PTEN	   ENST00000371953	   TTGGATGTGCAGCAGCTTACATGTCTGAAGTTACTTGAAGGCATCACTTTTAAGAAAGCT
TACAGTTGGGCCCTGTACCATCCCAAGTCCTTTGTAGCTC	  
rbpj_sp2	   ENST00000506956,	  ENST00000514807,	  ENST00000355476,	  ENST00000504907,	  
ENST00000511546,	  ENST00000342320,	  ENST00000509158,	  ENST00000511451,	  




RCOR1	   ENST00000262241,	  ENST00000570597	   GAAGGAACCACACCCCAGTTGTGCCGATTACATTAGTGTTGGCACACAGTCGGGTGCTA
GTGTAACACAAATGCCGCGTTGTCTGGGTGTACAGTGTTTG	  




rrad_common	   ENST00000299759,	  ENST00000420652,	  ENST00000566577,	  ENST00000568915	   ACTCAGACGAGAGCGTTTACAAGGTGCTGCTGCTGGGGGCGCCCGGCGTGGGCAAGAG
CGCCCTGGCGCGCATCTTCGGCGGTGTGGAGGACGGGCCTGA	  




Runx1_sp2	   ENST00000344691,	  ENST00000358356,	  ENST00000399240	   CCCTGTCGCCGTCTGGTAGGAGCTGTTTGCAGGGTCCTAACTCAATCGGCTTGTTGTGAT
GCGTATCCCCGTAGATGCCAGCACGAGCCGCC	  
SIN3A	   ENST00000394949,	  ENST00000360439,	  ENST00000394947	   CTTCTATGGCAGATGCCAGCAAACATGGTGGTGGAACAGAATCGTTATTTTTTGATAAGG
TCCGAAAGGCTCTTCGGAGTGCAGAAGCCTACGAAAATTT	  
SOX2	   ENST00000325404,	  ENST00000431565	   GCCTTTCCAAAAAATAATAATAACAATCATCGGCGGCGGCAGGATCGGCCAGAGGAGGA
GGGAAGCGCTTTTTTTGATCCTGATTCCAGTTTGCCTCTCT	  
SOX4	   ENST00000244745,	  ENST00000543472	   GCATGCAGGCTTTTTGGCTTCCTACCTTGCAACAAAATAATTGCACCAACTCCTTAGTGCC
GATTCCGCCCACAGAGAGTCCTGGAGCCACAGTCTTTTT	  
SP1	   ENST00000426431	   AGCCCTGGTGCTACTTGCTTGAAGTTTTCAGTGTAAGTACCCTGATGCCTTTTGGACCTTG
GGATCAGATCAAGAGTTTTGGAGATCAGGTACCAAGGAA	  
SREBF2	   ENST00000361204,	  ENST00000424354,	  ENST00000491541	   CTGAGTTGCTGTAGCGTCTTGATTCTCTCCCTGGGTCTGCGTTCCCTCCCCTGGGCCTGAC
TGAGCCTGCTCATTGTTTTTCCCTTTATTACACAGGACA	  
SRF	   ENST00000265354	   AGAGCCTACCTTCACCACCTATATCCAGAAGGGGAGCTTTTTCAGAAACAGGGCAGCAGT
GGGGTGAAATTTTCTTAACCCCTAAGACTGCCTTCAGTAG	  




STAT2	   ENST00000314128,	  ENST00000555665,	  ENST00000556539,	  ENST00000557235	   CAACATTTTAATAGTTGGTTAGGCTAAACTGGTGCATACTGGCATTGGCCCTTGGTGGGG
AGCACAGACACAGGATAGGACTCCATTTCTTTCTTCCATT	  




STAT5A	   ENST00000588868,	  ENST00000345506,	  ENST00000452307	   GCCGCCGGTTTGAGTGAGGGTTTCTGAGCTGCTCTGAATTAGTCCTTGCTTGGCTGCTTG
GCCTTGGGCTTCATTCAAGTCTATGATGCTGTTGCCCACG	  
STAT5B	   ENST00000293328	   GCCTAGAGAGTGGAGATTTTTGATGAAAGGTGTGCTCGCTCTCTGCGTTCTATCTTCTCTC
TCCTCCTTGTTCCTGCAAACCACAAGATAAAGGTAGTGG	  
TAF1_sp1	   ENST00000449580,	  ENST00000373790	   CCAATGAAGAAGGATAAGGACCAGGATTCTATTACTGGTGAGAAAGTGGACTTCAGTAG
TTCCTCTGACTCAGAATCTGAGATGGGACCT	  
TAF1_sp2	   ENST00000276072,	  ENST00000423759	   CCAATGAAGAAGGATAAGGACCAGGATTCTATTACTGGTGTGTCTGAAAATGGAGAAGG
CATCATCTTGCCCTCCATCATTGCCCCTTCC	  
TCF12_common_T	   ENST00000267811,	  ENST00000333725,	  ENST00000438423,	  ENST00000452095,	  
ENST00000557843,	  ENST00000559609,	  ENST00000560190,	  ENST00000561449,	  




TCF3_sp2_T	   ENST00000593064,	  ENST00000588136	   CCCACCCAGGCCTGAGCGAAGCCCACAACCCCGCCGGGCACATGTGAAAGTAAACAAAA
CCTGAAAGCAAGCAACAAAACATACACTTTGTCAGAGAAGA	  








TCF3_sp5_T	   ENST00000588136,	  ENST00000453954,	  ENST00000344749,	  ENST00000585731,	  
ENST00000585855,	  ENST00000590684,	  ENST00000592395	  
CCTGCAGCAGGCCGTGCAGGTCATCCTGGGGCTGGAGCAGCAGGTGCGAGAGCGGAAC
CTGAATCCCAAAGCAGCCTGTTTGAAACGGCGAGAAGAGGAA	  
TCF3_sp6_T	   ENST00000395423	   CGGGAAGGGCCGGCCCGCCTCCCTGGCCGGGGCGCAGTTCGGAGGTTCAGGCAAGAGC
GGTGAGCGGGGCGCCTATGCCTCCTTCGGGAGAGACGCAGGC	  
TCF3_sp7_T	   ENST00000588136,	  ENST00000344749,	  ENST00000262965	   GTCGCACAGCAGCCTCTCTTCATCCACATTCCTGGGACCGGGACTCGGAGGCAAGAGCG
GTGAGCGGGGCGCCTATGCCTCCTTCGGGAGAGACGCAGGC	  
TNFRSF13B	   ENST00000261652,	  ENST00000437538,	  ENST00000579315,	  ENST00000581616,	  
ENST00000582931,	  ENST00000583789,	  ENST00000584950	  
AGGAGCAAGGCAAGTTCTATGACCATCTCCTGAGGGACTGCATCAGCTGTGCCTCCATCT
GTGGACAGCACCCTAAGCAATGTGCATACTTCTGTGAGAA	  
TNFRSF13C	   ENST00000291232	   GTTTGGTGTGCTTGCCTTTGGCTTCAGACCTCACCATCTTTGACAGCCCTTGAAGGTGGTA
GCCCAGCTCCTGTTCCTGTGCCTTCAAAAGGCTGGGGCA	  
TNFRSF17_sp1	   ENST00000053243	   GCTAAGGAAGATAAACTCTGAACCATTAAAGGACGAGTTTAAAAACACAGGATCAGGTC
TCCTGGGCATGGCTAACATTGACCTGGAAAAGAGCAGGACT	  
TNFSF13B	   ENST00000375887,	  ENST00000430559	   AACAGGAAATGATCCATTCCCTGTGGTCACTTATTCTAAAGGCCCCAACCTTCAAAGTTCA
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AGTAGTGATATGGATGACTCCACAGAAAGGGAGCAGTCA	  
USF1_common_T	   ENST00000368019,	  ENST00000368021,	  ENST00000435396,	  ENST00000472217,	  
ENST00000473969,	  ENST00000528768,	  ENST00000531842,	  ENST00000368020	  
AAGCTTGTGATTATATCCAGGAGCTTCGGCAGAGTAACCACCGCTTGTCTGAAGAACTGC
AGGGACTTGACCAACTGCAGCTGGACAATGACGTGCTTCG	  
YY1	   ENST00000262238,	  ENST00000554579,	  ENST00000554804,	  ENST00000555735	   ACATGCTAAGGCCAAAAACAACCAGTGAAAAGAAGAGAGAAGACCCTTCTCGACCACGG
GAAGCATCTTCCAGAAGTGTGATTGGGAATAAATATGCCTC	  
ZIC3	   ENST00000287538	   TCAGTTAGTGGCCATGACATCTCAATCTTGTACTTCAAAGACTGAGAAGCTGGATTTAATC
ATCCCTGCCCTACATATATAAACATAAGGTAACCTACTG	  
ZNF217_sp3_T	   ENST00000371471	   AGTCCCGGCCGCCGCCGCGCGAGGAAATGGCCGAGGAGCCGGAGCCGCAGGGTTTGGA
AATCCCTTGTCTCCAGGTTGCTGGGATTGACTTCTTGCTCAA	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Supplementary	  Table	  8.	  NanoString	  counts	  and	  RPKMs	  for	  predominant	  compatible	  isoforms	  	  
	   Nanocounts	   mGene	  graph	   Tromer	   SLIDE	  all	   mGene	   mTim	   AUGUSTUS	  all	   Cufflinks	   iReckon	  full	   iReckon	  ends	   Trembly	  all	   Transomics	  all	  
adar1_sp1	   2101	   8.019	   11.800	   0.000	   0.000	   4.737	   0.000	   12.261	   27.993	   23.975	   15.097	   0.000	  
adar1_sp2	   2321	   6.343	   10.100	   3.529	   15.642	   0.000	   13.182	   11.639	   0.422	   1.950	   0.732	   18.420	  
atf2_common	   4911	   6.016	   20.100	   6.902	   13.868	   12.906	   9.553	   12.499	   0.000	   15.860	   5.974	   0.000	  
atf2_sp1	   2299	   6.016	   19.100	   0.000	   0.000	   12.906	   0.000	   2.711	   0.000	   4.636	   1.503	   0.000	  
atf2_sp2	   2156	   4.211	   54.300	   6.902	   13.868	   0.000	   9.553	   12.499	   0.000	   15.860	   5.974	   21.380	  
ATP5J_common	   16504	   6.764	   4.800	   10.377	   18.577	   32.224	   33.923	   174.528	   61.534	   50.080	   30.978	   22.280	  
Bcl11a_sp1	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
Bcl11a_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
BCL3	   1737	   0.000	   1.700	   0.884	   0.557	   3.767	   2.791	   6.189	   5.926	   2.468	   0.000	   3.780	  
BHLHB2	   17578	   39.789	   36.600	   29.947	   62.179	   84.314	   51.583	   0.000	   107.521	   87.483	   53.854	   0.000	  
Blnk_sp1_T	   33	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.008	   0.000	   0.000	   10.930	  
Blnk_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
CARM1_sp1_T	   1168	   4.848	   3.700	   0.000	   0.000	   9.981	   8.519	   19.494	   0.000	   18.037	   9.809	   0.000	  
CD19	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.067	   0.071	   0.000	   0.000	  
Cd79b_sp1_T	   24	   0.000	   0.000	   0.000	   0.043	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
Cd79b_sp2_T	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.018	   0.000	   0.000	   0.000	   0.000	   0.000	  
cdkn1a_sp1_T	   6057	   21.884	   0.000	   0.000	   0.000	   0.000	   21.888	   43.565	   53.015	   42.893	   29.102	   0.000	  
cdkn1a_sp2_T	   5429	   5.581	   0.000	   0.000	   0.000	   11.081	   0.000	   0.000	   0.702	   0.793	   1.044	   0.000	  
CEBPA	   7109	   0.000	   0.000	   7.464	   0.000	   0.000	   8.776	   0.000	   21.206	   8.371	   0.000	   0.000	  
CTCF_common	   255	   9.574	   10.600	   1.337	   11.822	   10.033	   8.977	   16.957	   20.358	   16.725	   11.564	   0.000	  
CTCF_sp1	   563	   9.574	   8.400	   2.043	   11.822	   10.033	   8.977	   16.957	   20.358	   16.725	   11.564	   0.000	  
CTCFL_sp1	   19	   0.000	   0.000	   0.000	   0.000	   0.000	   0.261	   0.000	   0.000	   0.000	   0.000	   0.060	  
CTCFL_sp2	   11	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
CTDSL_sp2_T	   940	   18.993	   37.300	   0.000	   20.476	   3.870	   9.696	   16.728	   0.000	   22.162	   7.568	   17.710	  
CTDSP1_common_T	   4117	   10.701	   22.100	   8.134	   20.135	   14.558	   11.711	   14.311	   25.545	   20.837	   9.889	   42.120	  
CTDSP2	   3330	   0.000	   0.000	   14.322	   0.000	   0.000	   25.306	   23.741	   44.528	   38.755	   20.104	   0.000	  
CTDSPL_sp1	   4193	   18.993	   36.700	   0.000	   20.476	   3.870	   5.744	   11.590	   0.000	   6.027	   5.331	   0.000	  
DES	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.018	   0.000	   0.000	   0.000	   0.000	   0.000	  
DNMT1_common_T	   1011	   2.208	   0.000	   2.193	   6.619	   2.270	   3.566	   7.063	   11.401	   6.460	   4.820	   6.190	  
E2F4	   4533	   16.233	   0.000	   0.000	   19.528	   14.254	   13.402	   23.889	   29.670	   25.409	   16.069	   17.580	  
E2F6_common	   5693	   3.922	   1.500	   1.555	   5.451	   0.000	   4.099	   0.000	   0.000	   0.000	   5.260	   2.960	  
ebf1_sp1	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
EGR1	   956	   7.684	   8.700	   2.694	   7.895	   8.305	   4.390	   8.910	   10.040	   8.180	   6.463	   0.000	  
EOMES_common	   14	   0.000	   0.000	   0.007	   0.000	   0.000	   0.005	   0.000	   0.000	   0.000	   0.000	   0.170	  
EP300	   1914	   11.002	   16.700	   2.775	   11.107	   10.824	   8.552	   14.063	   16.915	   13.800	   8.142	   12.510	  
esr1_common	   12	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
esr2_sp1	   33	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
esr2_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.020	  
ets1_common	   561	   0.000	   0.600	   0.566	   0.307	   0.000	   0.210	   0.376	   0.303	   0.153	   0.368	   0.320	  
FBXO15	   14	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.010	  
FOS	   755	   1.783	   2.400	   0.542	   1.783	   0.000	   1.255	   2.589	   2.962	   2.395	   1.888	   0.000	  
foxa2_body	   8700	   14.687	   16.500	   3.488	   17.953	   0.000	   12.329	   21.703	   14.811	   12.235	   15.405	   0.000	  
foxa2_sp2_T	   250	   0.000	   0.000	   3.488	   0.000	   17.363	   0.000	   4.916	   11.101	   8.888	   15.405	   0.000	  
FOXA3	   1223	   9.923	   17.100	   3.160	   12.663	   11.999	   8.652	   17.657	   19.049	   15.646	   10.745	   0.000	  
gabpa_sp1_T	   251	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.681	   0.000	   1.288	   0.000	  
gabpa_sp2_T	   237	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   1.386	   0.256	   0.000	   0.000	  
GATA1_T	   12	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   11.040	  
HDAC1	   7349	   9.321	   15.100	   7.233	   37.448	   24.484	   0.000	   45.483	   48.939	   38.679	   30.272	   0.000	  
HDAC3_sp1	   3703	   7.760	   10.500	   0.000	   7.760	   0.000	   13.394	   26.599	   0.000	   23.591	   15.355	   12.670	  
HDAC4	   902	   0.000	   3.100	   0.786	   0.000	   1.532	   0.000	   0.825	   3.016	   0.093	   0.813	   0.000	  
HDAC5	   65	   0.000	   0.000	   0.445	   0.000	   0.000	   0.000	   0.000	   0.000	   1.188	   13.694	   0.000	  
Hif1a_common	   13561	   18.760	   21.500	   7.487	   27.504	   18.168	   13.669	   33.054	   21.754	   18.023	   17.016	   26.690	  
HNF1A	   1485	   8.247	   3.600	   0.754	   8.251	   9.176	   4.968	   2.700	   10.798	   7.026	   3.155	   10.810	  
HNF1B	   836	   2.287	   4.400	   1.487	   2.903	   2.837	   1.275	   2.439	   2.896	   2.302	   1.823	   2.570	  
Hnf4g_common_T	   1906	   2.897	   3.600	   0.793	   3.550	   0.000	   0.000	   3.802	   4.060	   1.977	   2.896	   0.000	  
HSF1	   4997	   13.666	   10.900	   0.348	   19.782	   9.781	   18.878	   22.358	   39.006	   28.277	   8.647	   15.140	  
IGF1R_common_T	   2654	   5.520	   25.300	   2.545	   12.103	   7.032	   4.483	   12.120	   10.999	   12.999	   5.215	   10.780	  
IKZF1_common	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF1_sp1_T	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF1_sp2	   16	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF3_sp1_T	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.060	  
IKZF3_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IL6	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.011	   0.000	   0.000	   0.000	   0.000	   0.000	  
IL6receptor_common	   2319	   6.038	   10.300	   2.339	   6.584	   6.117	   0.000	   8.476	   9.792	   8.532	   5.920	   0.000	  
IL8	   84	   0.298	   0.000	   0.817	   0.298	   0.000	   0.031	   0.000	   0.516	   0.231	   0.000	   0.000	  
IL8RA	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IL8RB	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IRF8	   18	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
JUND	   297	   38.720	   0.000	   115.202	   38.720	   0.000	   0.000	   0.000	   56.163	   45.642	   0.000	   0.000	  
KAISO_sp1_T	   1368	   4.853	   0.000	   2.190	   4.853	   0.000	   2.848	   4.740	   6.764	   5.589	   4.147	   0.000	  
KAP1_common_T	   0	   48.402	   22.000	   1.195	   53.394	   48.369	   49.948	   91.944	   2.299	   65.311	   68.574	   62.880	  
KLF4	   226	   0.536	   1.200	   0.504	   0.536	   0.000	   0.000	   0.598	   0.692	   0.466	   0.944	   0.000	  
LEF1_sp1	   0	   0.000	   0.000	   0.000	   0.102	   0.000	   0.000	   0.000	   0.046	   0.000	   0.000	   0.000	  
LEF1_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
LIN28_common	   0	   0.000	   0.000	   0.000	   0.043	   0.000	   0.011	   0.000	   0.000	   0.000	   0.000	   0.010	  
MAX_sp1	   2984	   6.122	   7.900	   0.000	   5.156	   6.801	   4.591	   10.640	   0.000	   3.786	   4.277	   8.040	  
mef2a_common_T	   515	   1.998	   0.000	   1.386	   4.385	   5.082	   2.034	   4.035	   5.451	   4.205	   2.928	   4.700	  
mef2a_sp3	   1470	   1.998	   8.000	   0.309	   0.000	   5.082	   2.034	   4.035	   5.451	   4.205	   2.928	   0.000	  
mef2a_sp4	   1090	   1.266	   7.600	   1.386	   4.385	   0.000	   0.851	   1.627	   1.744	   1.473	   0.892	   4.700	  
mef2b_sp10_T	   81	   0.000	   8.000	   0.000	   0.000	   0.000	   4.953	   0.000	   0.000	   1.182	   0.000	   2.280	  
mef2b_sp11_T	   248	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.074	   0.193	   0.000	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   Nanocounts	   mGene	  graph	   Tromer	   SLIDE	  all	   mGene	   mTim	   AUGUSTUS	  all	   Cufflinks	   iReckon	  full	   iReckon	  ends	   Trembly	  all	   Transomics	  all	  
mef2b_sp12	   311	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   1.182	   0.882	   0.000	  
mef2b_sp7_T	   215	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   1.424	   0.000	  
mef2c_sp1	   9	   3.852	   2.200	   1.395	   3.852	   0.000	   2.842	   3.425	   0.000	   0.000	   0.000	   0.000	  
mef2c_sp3	   18	   60.369	   54.200	   10.330	   72.155	   47.513	   45.253	   60.126	   0.000	   0.000	   0.000	   0.000	  
mef2c_sp4	   16	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
mef2d_sp4	   80	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   3.045	   2.576	   3.004	   0.000	  
MYC	   28966	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   78.566	   69.472	   40.507	   0.000	  
MYF5	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.070	  
MYF6	   51	   3.416	   9.700	   1.049	   0.000	   2.773	   1.998	   6.599	   0.000	   0.000	   0.000	   7.360	  
MYOD1	   32	   5.066	   0.000	   1.638	   3.331	   3.444	   2.847	   9.295	   0.000	   0.000	   0.000	   4.760	  
NANOG	   64	   0.226	   0.000	   0.000	   0.226	   0.000	   2.475	   0.000	   0.000	   0.011	   0.000	   0.190	  
ncor2_sp1_T	   1143	   8.053	   0.000	   0.000	   8.053	   0.000	   5.163	   9.870	   0.000	   1.034	   2.510	   11.050	  
NFKB1_common	   355	   1.011	   0.000	   0.000	   1.011	   3.434	   1.299	   0.504	   4.062	   4.897	   3.380	   0.980	  
NOTCH1	   27	   6.427	   8.000	   1.518	   6.427	   0.000	   3.314	   6.747	   0.284	   0.032	   0.000	   0.000	  
NR2F2_sp2_T	   800	   4.323	   4.400	   0.963	   4.323	   0.000	   2.183	   2.163	   4.223	   3.783	   7.895	   0.000	  
OCT4_common	   284	   0.000	   0.000	   0.023	   0.000	   0.000	   0.000	   0.000	   0.084	   1.796	   0.000	   0.000	  
ONECUT1	   2013	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.823	   7.115	   5.992	   5.487	   0.000	  
ONECUT2	   805	   0.752	   0.000	   0.000	   1.089	   1.154	   0.774	   1.008	   4.046	   3.806	   3.005	   0.960	  
pbx1_common	   0	   2.905	   0.000	   1.231	   2.905	   2.990	   2.404	   4.568	   0.001	   0.000	   0.000	   3.320	  
pbx3_sp1	   97	   15.249	   0.000	   7.541	   17.974	   15.275	   13.497	   22.026	   0.702	   0.592	   0.000	   20.140	  
pbx3_sp2_T	   89	   0.000	   0.000	   0.828	   0.000	   3.434	   1.299	   0.000	   1.215	   1.032	   0.860	   0.980	  
PER1	   452	   3.611	   2.700	   0.000	   4.498	   0.000	   0.000	   0.000	   5.530	   4.592	   3.320	   0.000	  
POLR2A	   4377	   0.000	   3.900	   0.000	   0.000	   0.000	   2.728	   5.559	   31.669	   26.517	   18.840	   0.000	  
POU5F1_T	   94	   0.000	   7.800	   0.888	   0.000	   5.158	   3.436	   0.000	   0.084	   1.796	   0.000	   0.000	  
PTEN	   1128	   0.629	   0.000	   0.258	   2.280	   0.000	   1.567	   1.227	   4.292	   1.040	   0.000	   3.240	  
rbpj_sp2	   82	   0.577	   1.300	   1.881	   0.577	   0.602	   0.407	   1.140	   0.000	   5.918	   2.401	   0.700	  
RCOR1	   2199	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   8.782	   6.885	   5.339	   0.000	  
RELL2_common_T	   226	   0.000	   0.000	   0.600	   0.000	   0.000	   1.474	   3.147	   0.000	   0.000	   1.725	   0.000	  
rrad_common	   82	   5.612	   10.400	   1.445	   6.486	   5.683	   4.965	   8.384	   0.409	   0.740	   0.000	   6.620	  
Runx1_sp1	   24	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
Runx1_sp2	   338	   0.000	   4.600	   1.114	   0.000	   0.000	   0.000	   0.000	   1.734	   1.439	   1.291	   0.000	  
SIN3A	   1241	   0.000	   7.300	   1.759	   0.000	   32.098	   0.000	   6.523	   5.741	   8.155	   0.000	   0.000	  
SOX2	   0	   28.334	   25.500	   14.937	   50.738	   27.716	   37.410	   80.463	   0.000	   0.034	   0.000	   0.000	  
SOX4	   528	   0.000	   12.200	   4.700	   0.000	   14.379	   7.759	   13.846	   0.063	   2.135	   0.000	   0.000	  
SP1	   513	   8.426	   0.000	   3.291	   9.046	   7.994	   7.303	   12.281	   7.665	   6.247	   5.301	   3.290	  
SREBF2	   7451	   3.716	   6.000	   1.516	   6.431	   0.000	   2.611	   8.957	   84.859	   3.228	   46.195	   0.000	  
SRF	   790	   8.985	   3.300	   7.878	   26.855	   10.632	   10.560	   30.035	   17.672	   14.304	   12.139	   21.140	  
stat1_common	   1154	   1.007	   1.700	   0.416	   1.491	   0.000	   0.000	   1.743	   13.717	   10.893	   8.726	   0.000	  
STAT2	   1235	   7.422	   0.000	   4.175	   9.714	   0.000	   6.814	   12.711	   2.849	   6.198	   1.597	   0.000	  
stat3_common	   7640	   0.000	   2.600	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   5.170	   0.000	  
STAT5A	   396	   0.960	   3.000	   1.889	   2.421	   0.000	   1.776	   2.442	   1.113	   1.393	   1.264	   3.290	  
STAT5B	   1717	   2.932	   6.700	   1.193	   7.708	   5.653	   5.623	   8.754	   15.297	   12.872	   8.823	   5.400	  
TAF1_sp1	   270	   0.000	   0.000	   0.000	   0.000	   0.000	   3.949	   5.753	   0.136	   0.000	   0.000	   0.000	  
TAF1_sp2	   326	   0.000	   16.900	   3.247	   0.000	   0.000	   0.000	   7.678	   2.182	   0.000	   2.013	   0.000	  
TCF12_common_T	   2427	   1.818	   0.600	   0.000	   0.000	   0.000	   0.000	   7.183	   8.493	   6.724	   4.822	   0.000	  
TCF3_sp2_T	   1214	   1.903	   0.000	   3.247	   8.286	   0.000	   3.949	   7.678	   0.000	   10.253	   4.776	   10.600	  
TCF3_sp3_T	   1102	   1.818	   5.700	   0.000	   0.000	   1.393	   0.000	   0.000	   0.000	   5.126	   0.000	   0.000	  
TCF3_sp4	   1153	   1.650	   3.900	   0.000	   0.000	   4.494	   3.949	   7.183	   0.000	   8.657	   4.776	   10.600	  
TCF3_sp5_T	   1031	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   10.253	   2.450	   0.090	  
TCF3_sp6_T	   1111	   0.000	   0.400	   0.161	   0.158	   0.000	   0.000	   0.000	   0.000	   2.463	   4.776	   0.000	  
TCF3_sp7_T	   1646	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   10.253	   2.450	   0.000	  
TNFRSF13B	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   2.110	  
TNFRSF13C	   22	   2.951	   5.400	   2.270	   4.313	   2.831	   3.584	   5.177	   0.203	   0.125	   0.000	   3.250	  
TNFRSF17_sp1	   0	   17.687	   10.100	   5.461	   17.687	   17.874	   11.013	   13.888	   0.000	   0.000	   0.000	   0.000	  
TNFSF13B	   84	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.008	   0.018	   0.000	   0.000	  
USF1_common_T	   623	   0.000	   0.800	   5.349	   0.000	   0.000	   0.000	   13.414	   5.824	   4.726	   3.154	   0.000	  
YY1	   11801	   8.019	   11.800	   0.000	   0.000	   4.737	   0.000	   12.261	   22.801	   18.355	   11.602	   0.000	  
ZIC3	   46	   6.343	   10.100	   3.529	   15.642	   0.000	   13.182	   11.639	   0.000	   0.000	   0.000	   18.420	  
ZNF217_sp3_T	   1401	   6.016	   20.100	   6.902	   13.868	   12.906	   9.553	   12.499	   20.481	   15.954	   8.342	   0.000	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Supplementary	  Table	  9.	  NanoString	  counts	  and	  RPKMs	  for	  predominant	  isoforms	  	  
	   Nanocounts	   AUGUSTUS	  all	   Cufflinks	   iReckon	  full	   iReckon	  ends	   mGene	   mGene	  graph	   mTim	   SLIDE	  all	   Transomics	  all	   Trembly	  all	   Tromer	  
adar1_sp1	   2101	   13.182	   12.261	   27.993	   23.975	   15.642	   8.019	   4.737	   10.275	   18.420	   18.420	   29.500	  
adar1_sp2	   2321	   13.182	   12.261	   27.993	   23.975	   15.642	   8.019	   4.737	   10.275	   18.420	   18.420	   29.500	  
atf2_common	   4911	   9.553	   12.499	   0.000	   15.860	   13.868	   6.016	   12.906	   6.902	   21.380	   21.380	   54.300	  
atf2_sp1	   2299	   9.553	   12.499	   0.000	   15.860	   13.868	   6.016	   12.906	   6.902	   21.380	   21.380	   54.300	  
atf2_sp2	   2156	   9.553	   12.499	   0.000	   15.860	   13.868	   6.016	   12.906	   6.902	   21.380	   21.380	   54.300	  
ATP5J_common	   16504	   33.923	   174.528	   61.534	   50.080	   18.577	   6.764	   32.224	   10.377	   22.280	   22.280	   59.500	  
Bcl11a_sp1	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.140	   0.140	   0.000	  
Bcl11a_sp2	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.140	   0.140	   0.000	  
BCL3	   1737	   2.791	   6.189	   5.926	   3.573	   4.486	   4.486	   3.767	   1.557	   3.780	   3.780	   7.200	  
BHLHB2	   17578	   51.583	   82.714	   107.521	   87.483	   62.179	   39.789	   84.314	   29.947	   88.550	   88.550	   82.600	  
Blnk_sp1_T	   33	   0.007	   0.000	   0.008	   0.000	   7.716	   7.716	   0.000	   0.011	   10.930	   10.930	   0.000	  
Blnk_sp2	   0	   0.007	   0.000	   0.008	   0.000	   7.716	   7.716	   0.000	   0.011	   10.930	   10.930	   0.000	  
CARM1_sp1_T	   1168	   8.519	   19.494	   0.000	   18.037	   20.105	   9.535	   9.981	   3.743	   9.540	   9.540	   43.900	  
CD19	   0	   0.612	   2.669	   0.067	   0.071	   0.681	   0.000	   0.000	   7.420	   0.190	   0.190	   1.600	  
Cd79b_sp1_T	   24	   0.018	   0.000	   0.000	   0.000	   0.043	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
Cd79b_sp2_T	   0	   0.018	   0.000	   0.000	   0.000	   0.043	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
cdkn1a_sp1_T	   6057	   21.888	   43.565	   53.015	   42.893	   27.358	   21.884	   11.361	   5.722	   37.470	   37.470	   17.200	  
cdkn1a_sp2_T	   5429	   21.888	   43.565	   53.015	   42.893	   27.358	   21.884	   11.361	   5.722	   37.470	   37.470	   17.200	  
CEBPA	   7109	   8.776	   0.000	   21.206	   8.371	   5.980	   5.274	   0.000	   7.464	   6.380	   6.380	   0.000	  
CTCF_common	   255	   8.977	   16.957	   20.358	   16.725	   11.822	   9.574	   10.033	   3.169	   13.750	   13.750	   21.100	  
CTCF_sp1	   563	   8.977	   16.957	   20.358	   16.725	   11.822	   9.574	   10.033	   3.169	   13.750	   13.750	   21.100	  
CTCFL_sp1	   19	   0.261	   0.000	   0.012	   0.041	   0.099	   0.000	   0.000	   0.721	   0.060	   0.060	   0.200	  
CTCFL_sp2	   11	   0.261	   0.000	   0.012	   0.041	   0.099	   0.000	   0.000	   0.721	   0.060	   0.060	   0.200	  
CTDSL_sp2_T	   940	   9.696	   16.728	   0.000	   22.162	   20.476	   18.993	   19.435	   6.404	   17.710	   17.710	   37.300	  
CTDSP1_common_T	   4117	   11.711	   14.311	   25.545	   20.837	   20.135	   10.701	   14.558	   8.134	   42.120	   42.120	   38.700	  
CTDSP2	   3330	   25.306	   23.741	   44.528	   38.755	   30.798	   25.746	   24.823	   14.322	   20.100	   20.100	   22.300	  
CTDSPL_sp1	   4193	   9.696	   16.728	   0.000	   22.162	   20.476	   18.993	   19.435	   6.404	   17.710	   17.710	   37.300	  
DES	   0	   0.018	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
DNMT1_common_T	   1011	   3.566	   12.116	   11.401	   6.460	   6.619	   2.208	   2.270	   2.888	   6.190	   6.190	   16.400	  
E2F4	   4533	   13.402	   23.889	   29.670	   25.409	   19.528	   16.233	   14.254	   3.340	   17.580	   17.580	   35.100	  
E2F6_common	   5693	   4.099	   7.950	   0.000	   0.000	   5.451	   3.922	   4.733	   2.139	   2.960	   2.960	   8.000	  
ebf1_sp1	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
EGR1	   956	   4.390	   8.910	   10.040	   8.180	   7.895	   7.684	   8.305	   2.694	   9.340	   9.340	   8.700	  
EOMES_common	   14	   0.005	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.007	   0.170	   0.170	   0.000	  
EP300	   1914	   8.552	   14.063	   16.915	   13.800	   11.107	   11.002	   10.824	   2.775	   12.510	   12.510	   18.200	  
esr1_common	   12	   0.000	   0.000	   0.000	   0.001	   0.005	   0.000	   0.000	   0.001	   0.000	   0.000	   0.000	  
esr2_sp1	   33	   0.000	   0.000	   0.000	   0.081	   0.087	   0.000	   0.000	   1.196	   0.020	   0.020	   0.200	  
esr2_sp2	   0	   0.000	   0.000	   0.000	   0.081	   0.087	   0.000	   0.000	   1.196	   0.020	   0.020	   0.200	  
ets1_common	   561	   0.210	   0.376	   0.303	   0.153	   0.307	   0.000	   0.000	   0.566	   0.320	   0.320	   0.600	  
FBXO15	   14	   0.000	   0.000	   0.000	   0.000	   0.016	   0.000	   0.000	   0.938	   0.010	   0.010	   0.300	  
FOS	   755	   1.255	   2.589	   2.962	   2.395	   1.783	   1.783	   0.000	   1.000	   2.290	   2.290	   2.400	  
foxa2_body	   8700	   12.329	   21.703	   14.811	   12.235	   17.953	   14.687	   17.363	   3.488	   18.410	   18.410	   33.200	  
foxa2_sp2_T	   250	   12.329	   21.703	   14.811	   12.235	   17.953	   14.687	   17.363	   3.488	   18.410	   18.410	   33.200	  
FOXA3	   1223	   8.652	   17.657	   19.049	   15.646	   12.663	   9.923	   11.999	   3.160	   11.930	   11.930	   17.100	  
gabpa_sp1_T	   251	   2.389	   6.092	   2.225	   0.256	   2.723	   1.769	   0.000	   1.391	   3.480	   3.480	   6.400	  
gabpa_sp2_T	   237	   2.389	   6.092	   2.225	   0.256	   2.723	   1.769	   0.000	   1.391	   3.480	   3.480	   6.400	  
GATA1_T	   12	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   11.040	   11.040	   0.000	  
HDAC1	   7349	   27.696	   86.127	   48.939	   38.679	   37.448	   9.321	   24.484	   7.233	   27.570	   27.570	   44.600	  
HDAC3_sp1	   3703	   13.394	   26.599	   0.000	   23.591	   20.748	   20.748	   19.399	   4.831	   12.670	   12.670	   21.700	  
HDAC4	   902	   0.863	   1.522	   3.016	   2.396	   2.217	   0.943	   1.532	   0.786	   1.720	   1.720	   8.300	  
HDAC5	   65	   12.839	   26.933	   0.000	   47.104	   33.155	   7.620	   15.081	   18.303	   26.610	   26.610	   72.300	  
Hif1a_common	   13561	   13.669	   33.054	   21.754	   18.023	   27.504	   18.760	   18.168	   7.487	   26.690	   26.690	   32.500	  
HNF1A	   1485	   4.968	   2.700	   10.798	   7.026	   8.251	   8.247	   9.176	   2.089	   10.810	   10.810	   3.600	  
HNF1B	   836	   1.275	   2.439	   2.896	   2.302	   2.903	   2.287	   2.837	   1.487	   2.570	   2.570	   6.600	  
Hnf4g_common_T	   1906	   2.359	   3.802	   4.060	   1.977	   3.550	   2.897	   2.040	   0.818	   1.220	   1.220	   4.200	  
HSF1	   4997	   18.878	   22.358	   39.006	   28.277	   19.782	   13.666	   9.781	   5.110	   15.140	   15.140	   65.500	  
IGF1R_common_T	   2654	   9.782	   12.120	   10.999	   12.999	   17.784	   17.784	   7.032	   2.545	   14.320	   14.320	   25.300	  
IKZF1_common	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF1_sp1_T	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF1_sp2	   16	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
IKZF3_sp1_T	   0	   0.000	   0.000	   0.000	   0.015	   11.141	   3.412	   0.000	   0.000	   0.060	   0.060	   0.000	  
IKZF3_sp2	   0	   0.000	   0.000	   0.000	   0.015	   11.141	   3.412	   0.000	   0.000	   0.060	   0.060	   0.000	  
IL6	   0	   0.011	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.010	   0.010	   0.000	  
IL6receptor_common	   2319	   4.373	   8.476	   9.792	   8.532	   6.584	   6.038	   6.117	   3.045	   5.370	   5.370	   14.900	  
IL8	   84	   0.031	   0.475	   0.516	   0.231	   0.298	   0.298	   0.000	   0.817	   0.160	   0.160	   0.500	  
IL8RA	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.030	   0.030	   0.000	  
IL8RB	   0	   0.013	   0.000	   0.000	   0.000	   0.029	   0.000	   0.000	   0.262	   0.010	   0.010	   0.000	  
IRF8	   18	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
JUND	   297	   25.218	   0.000	   56.163	   45.642	   38.720	   38.720	   0.000	   115.202	   46.830	   46.830	   0.000	  
KAISO_sp1_T	   1368	   2.848	   4.740	   6.764	   5.589	   4.853	   4.853	   0.000	   2.190	   4.920	   4.920	   6.000	  
KAP1_common_T	   0	   49.948	   91.944	   119.818	   65.311	   53.394	   48.402	   48.369	   23.632	   62.880	   62.880	   145.100	  
KLF4	   226	   0.137	   0.598	   0.692	   0.466	   0.536	   0.536	   0.000	   0.504	   0.370	   0.370	   1.200	  
LEF1_sp1	   0	   0.030	   0.000	   0.046	   0.006	   0.102	   0.000	   0.000	   0.000	   0.040	   0.040	   0.300	  
LEF1_sp2	   0	   0.030	   0.000	   0.046	   0.006	   0.102	   0.000	   0.000	   0.000	   0.040	   0.040	   0.300	  
LIN28_common	   0	   0.011	   0.000	   0.000	   0.000	   0.043	   0.000	   0.000	   0.000	   0.010	   0.010	   0.000	  
MAX_sp1	   2984	   4.591	   10.640	   0.000	   3.786	   5.156	   6.122	   6.801	   2.226	   8.040	   8.040	   7.900	  
mef2a_common_T	   515	   2.034	   4.035	   5.451	   4.205	   4.385	   1.998	   5.082	   1.386	   4.700	   4.700	   9.200	  
mef2a_sp3	   1470	   2.034	   4.035	   5.451	   4.205	   4.385	   1.998	   5.082	   1.386	   4.700	   4.700	   9.200	  
mef2a_sp4	   1090	   2.034	   4.035	   5.451	   4.205	   4.385	   1.998	   5.082	   1.386	   4.700	   4.700	   9.200	  
mef2b_sp10_T	   81	   4.953	   3.464	   0.000	   1.182	   1.384	   1.088	   1.294	   1.760	   2.280	   2.280	   8.000	  
mef2b_sp11_T	   248	   0.000	   0.000	   0.000	   3.168	   0.000	   0.000	   0.000	   0.000	   0.000	   2.280	   0.000	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mef2b_sp12	   311	   0.000	   0.000	   0.000	   3.168	   0.000	   0.000	   0.000	   0.000	   0.000	   2.280	   0.000	  
mef2b_sp7_T	   215	   0.000	   0.000	   0.000	   3.168	   0.000	   0.000	   0.000	   0.000	   0.000	   2.280	   0.000	  
mef2c_sp1	   9	   2.842	   3.425	   0.002	   0.000	   3.852	   3.852	   0.000	   1.395	   3.900	   0.000	   8.200	  
mef2c_sp3	   18	   45.253	   60.126	   0.002	   0.000	   72.155	   60.369	   47.513	   16.867	   103.100	   0.000	   54.200	  
mef2c_sp4	   16	   0.733	   0.000	   0.002	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	  
mef2d_sp4	   80	   0.733	   0.000	   3.045	   2.576	   0.000	   0.000	   0.000	   0.000	   0.000	   3.900	   0.000	  
MYC	   28966	   0.000	   0.000	   78.566	   69.472	   0.000	   0.000	   0.000	   0.000	   0.000	   103.100	   0.000	  
MYF5	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.070	   0.000	   0.000	  
MYF6	   51	   1.998	   6.599	   0.000	   0.000	   8.090	   3.416	   2.773	   5.106	   7.360	   0.000	   24.700	  
MYOD1	   32	   2.847	   9.295	   0.000	   0.000	   3.331	   5.066	   3.444	   1.638	   4.760	   0.000	   9.700	  
NANOG	   64	   2.475	   0.496	   0.000	   0.011	   0.226	   0.226	   0.000	   0.310	   0.190	   0.070	   0.500	  
ncor2_sp1_T	   1143	   5.163	   9.870	   0.000	   7.648	   8.053	   8.053	   9.022	   2.367	   11.050	   7.360	   5.800	  
NFKB1_common	   355	   1.299	   0.504	   4.062	   4.897	   1.011	   1.011	   3.434	   0.828	   0.980	   4.760	   0.000	  
NOTCH1	   27	   3.314	   6.747	   0.284	   0.062	   6.427	   6.427	   4.973	   1.518	   4.420	   0.190	   8.000	  
NR2F2_sp2_T	   800	   2.183	   2.163	   6.076	   4.056	   4.323	   4.323	   0.000	   0.963	   1.900	   11.050	   4.400	  
OCT4_common	   284	   0.000	   0.000	   0.084	   1.796	   0.000	   0.000	   0.000	   0.023	   0.010	   0.980	   0.000	  
ONECUT1	   2013	   0.774	   1.008	   7.115	   5.992	   1.089	   0.752	   1.154	   0.476	   0.960	   4.420	   2.100	  
ONECUT2	   805	   0.774	   1.008	   4.046	   3.806	   1.089	   0.752	   1.154	   0.476	   0.960	   1.900	   2.100	  
pbx1_common	   0	   2.404	   4.568	   0.001	   0.000	   2.905	   2.905	   10.530	   1.598	   3.320	   0.010	   2.300	  
pbx3_sp1	   97	   13.497	   22.026	   1.215	   1.032	   17.974	   15.249	   15.275	   7.810	   20.140	   0.960	   30.500	  
pbx3_sp2_T	   89	   1.299	   0.504	   1.215	   1.032	   1.011	   1.011	   3.434	   0.828	   0.980	   0.960	   0.000	  
PER1	   452	   5.492	   7.897	   5.530	   4.592	   4.498	   3.611	   0.000	   3.308	   35.660	   3.320	   7.000	  
POLR2A	   4377	   2.927	   11.227	   31.669	   26.517	   6.303	   3.903	   6.441	   2.160	   1.790	   20.140	   9.700	  
POU5F1_T	   94	   3.436	   6.237	   0.084	   1.796	   4.716	   4.716	   5.158	   0.888	   2.200	   0.980	   7.800	  
PTEN	   1128	   1.567	   1.227	   4.292	   4.046	   2.280	   0.629	   0.000	   0.696	   3.240	   35.660	   3.100	  
rbpj_sp2	   82	   0.407	   1.140	   0.000	   5.918	   0.577	   0.577	   0.602	   1.881	   0.700	   1.790	   21.000	  
RCOR1	   2199	   1.474	   3.147	   8.782	   6.885	   1.992	   1.741	   2.388	   0.991	   1.860	   2.200	   4.600	  
RELL2_common_T	   226	   1.474	   3.147	   0.000	   1.064	   1.992	   1.741	   2.388	   0.991	   1.860	   3.240	   4.600	  
rrad_common	   82	   4.965	   8.384	   0.409	   0.740	   6.486	   5.612	   5.683	   1.445	   6.620	   0.700	   13.800	  
Runx1_sp1	   24	   0.008	   0.000	   1.734	   1.439	   0.022	   0.022	   0.000	   0.009	   0.020	   1.860	   0.000	  
Runx1_sp2	   338	   0.608	   0.000	   1.734	   1.439	   1.566	   1.566	   0.000	   1.114	   1.950	   1.860	   4.600	  
SIN3A	   1241	   61.269	   6.523	   5.741	   8.155	   5.816	   5.799	   32.098	   1.759	   6.870	   6.620	   8.800	  
SOX2	   0	   37.410	   80.463	   0.000	   0.034	   50.738	   28.334	   27.716	   14.937	   60.260	   0.020	   104.400	  
SOX4	   528	   7.759	   13.846	   0.063	   2.135	   11.998	   11.998	   14.379	   5.375	   11.910	   1.950	   12.200	  
SP1	   513	   7.303	   16.601	   7.665	   6.247	   9.046	   8.426	   7.994	   3.291	   3.290	   6.870	   18.900	  
SREBF2	   7451	   2.611	   8.957	   84.859	   70.533	   6.431	   3.716	   1.655	   2.549	   5.450	   60.260	   9.500	  
SRF	   790	   10.560	   30.035	   17.672	   14.304	   26.855	   8.985	   10.632	   10.479	   21.140	   11.910	   66.800	  
stat1_common	   1154	   0.911	   1.743	   13.717	   10.893	   1.491	   1.007	   1.712	   0.416	   5.160	   3.290	   2.200	  
STAT2	   1235	   6.814	   12.711	   2.849	   6.198	   9.714	   7.422	   8.864	   4.175	   8.570	   5.450	   19.700	  
stat3_common	   7640	   1.776	   5.084	   0.000	   0.000	   2.421	   0.960	   10.924	   1.889	   3.290	   21.140	   5.000	  
STAT5A	   396	   1.776	   5.084	   1.113	   1.393	   2.421	   0.960	   10.924	   1.889	   3.290	   5.160	   5.000	  
STAT5B	   1717	   5.623	   9.242	   15.297	   12.872	   7.708	   2.932	   5.653	   3.924	   5.400	   8.570	   13.600	  
TAF1_sp1	   270	   3.949	   7.678	   3.525	   6.240	   8.286	   1.903	   4.494	   3.247	   10.600	   3.290	   16.900	  
TAF1_sp2	   326	   3.949	   7.678	   3.525	   6.240	   8.286	   1.903	   4.494	   3.247	   10.600	   3.290	   16.900	  
TCF12_common_T	   2427	   3.949	   7.678	   8.493	   6.724	   8.286	   1.903	   4.494	   3.247	   10.600	   5.400	   16.900	  
TCF3_sp2_T	   1214	   3.949	   7.678	   0.000	   10.253	   8.286	   1.903	   4.494	   3.247	   10.600	   10.600	   16.900	  
TCF3_sp3_T	   1102	   3.949	   7.678	   0.000	   10.253	   8.286	   1.903	   4.494	   3.247	   10.600	   10.600	   16.900	  
TCF3_sp4	   1153	   3.949	   7.678	   0.000	   10.253	   8.286	   1.903	   4.494	   3.247	   10.600	   10.600	   16.900	  
TCF3_sp5_T	   1031	   0.000	   0.000	   0.000	   10.253	   0.338	   0.000	   0.000	   0.031	   0.090	   10.600	   0.000	  
TCF3_sp6_T	   1111	   0.000	   0.000	   0.000	   10.253	   0.158	   0.000	   0.000	   0.161	   0.110	   10.600	   0.400	  
TCF3_sp7_T	   1646	   0.000	   0.000	   0.000	   10.253	   0.000	   0.000	   0.000	   0.000	   0.000	   10.600	   0.000	  
TNFRSF13B	   0	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   0.000	   2.110	   0.090	   0.000	  
TNFRSF13C	   22	   3.584	   5.177	   0.203	   0.125	   4.313	   2.951	   2.831	   2.270	   3.250	   0.110	   13.500	  
TNFRSF17_sp1	   0	   11.013	   13.888	   0.000	   0.000	   17.687	   17.687	   17.874	   5.461	   10.590	   0.000	   10.100	  
TNFSF13B	   84	   0.000	   0.000	   0.008	   0.018	   0.000	   0.000	   0.000	   0.000	   0.170	   2.110	   0.000	  
USF1_common_T	   623	   7.432	   13.414	   5.824	   4.726	   12.480	   9.747	   0.000	   5.349	   17.100	   3.250	   11.200	  
YY1	   11801	   13.182	   12.261	   22.801	   18.355	   15.642	   8.019	   4.737	   10.275	   18.420	   10.590	   29.500	  
ZIC3	   46	   13.182	   12.261	   0.000	   0.000	   15.642	   8.019	   4.737	   10.275	   18.420	   0.170	   29.500	  
ZNF217_sp3_T	   1401	   9.553	   12.499	   20.481	   15.954	   13.868	   6.016	   12.906	   6.902	   21.380	   17.100	   54.300	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Supplementary	  Table	  10.	  Summary	  of	  transcript	  reconstruction	  tools	  	  
Method	   URL	   Main	  application	   Additional	  features	  
AUGUSTUS1,2	   bioinf.uni-­‐greifswald.de/augustus	   Gene	  prediction,	  genome	  
annotation	  
Can	  incorporate	  external	  expression	  data	  (e.g.	  
SAGE	  or	  CAGE).	  Can	  make	  use	  of	  protein	  
homology	  information.	  
Cufflinks3	   cufflinks.cbcb.umd.edu	   Transcript	  assembly	  and	  
quantification	  
Can	  be	  run	  without	  or	  without	  gene	  
annotation,	  or	  optionally	  applied	  to	  quantify	  
known	  transcripts.	  Can	  correct	  for	  fragment	  
bias	  and	  improve	  transcript	  quantification	  if	  
provided	  with	  estimated	  pre-­‐mRNA	  levels.	  
Exonerate4	   www.ebi.ac.uk/~guy/exonerate	   Transcript	  assembly	  and	  
quantification	  
	  
GSTRUCT	   —	   Transcript	  assembly	  and	  
quantification	  
	  iReckon5	   compbio.cs.toronto.edu/ireckon	   Transcript	  assembly	  and	  
quantification	  
Can	  identify	  pre-­‐mRNAs	  and	  retained	  introns.	  
Can	  incorporate	  external	  expression	  data	  (e.g.	  
SAGE	  or	  CAGE).	  mGene6,7	   mgene.org	   Gene	  prediction,	  genome	  
annotation	  
	  mTim	   galaxy.raetschlab.org	   Transcript	  assembly	  and	  
quantification	  
Can	  use	  external	  gene	  expression,	  protein,	  
RepeatMasker	  or	  sequence	  conservation	  
data.	  Can	  identify	  open	  reading	  frames	  and	  
thus	  predict	  coding	  exons.	  NextGeneid8	   —	   Gene	  prediction,	  genome	  
annotation	  
	  Oases9	   www.ebi.ac.uk/~zerbino/oases	   De-­‐novo	  transcriptome	  assembly	   	  SLIDE10	   sites.google.com/site/jingyijli/SLIDE.zip	   Transcript	  assembly	  and	  
quantification	  
Can	  be	  applied	  to	  independent	  transcript	  
quantification.	  Can	  incorporate	  external	  
expression	  data	  (e.g.	  SAGE	  or	  CAGE).	  Transomics	   www.softberry.com	   Gene	  prediction,	  genome	  
annotation	  
	  Trembly	   —	   Transcript	  assembly	  and	  
quantification	   	  Tromer11	   tromer.sourceforge.net	   Transcript	  assembly	  and	  
quantification	   	  Velvet12	   www.ebi.ac.uk/~zerbino/velvet	   De-­‐novo	  genome	  assembly	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Supplementary	  Note:	  Description	  of	  transcript	  reconstruction	  protocols	  This	  document	  provides	  details	  about	  specific	  transcript	  reconstruction	  methods.	  For	  methods	  that	  underlie	  several	  protocols,	  subheadings	  designate	  procedural	  variants.	  All	  protocols	  used	  the	  same	  reference	  genome	  sequences:	  H.	  sapiens	  assembly	  GRCh37,	  D.	  melanogaster	  release	  5	  from	  the	  Berkeley	  Drosophila	  Genome	  Project,	  and	  C.	  elegans	  assembly	  WS200.	  See	  also	  Supplementary	  Table	  1,	  where	  details	  of	  the	  protocols	  are	  tabulated,	  including	  the	  alignment	  programs	  used	  to	  map	  RNA-­‐seq	  reads	  to	  the	  genome	  sequences.	  
1.	  AUGUSTUS	  The	  gene	  finder	  AUGUSTUS	  was	  initially	  built	  to	  predict	  gene	  structures	  from	  genomic	  sequences	  alone1.	  An	  extended	  version	  of	  the	  generalized	  hidden	  Markov	  model	  used	  by	  AUGUSTUS	  was	  developed	  to	  incorporate	  evidence	  from	  external	  sources,	  such	  as	  syntenic	  genomic	  sequences	  or	  expressed	  sequence	  tags2.	  Such	  data	  is	  used	  to	  inform	  the	  detection	  of	  start	  and	  stop	  codons,	  acceptor	  and	  donor	  splice	  sites,	  and	  exonic	  regions.	  For	  each	  triple	  of	  a	  genomic	  sequence,	  a	  gene	  structure,	  and	  a	  set	  of	  hints,	  AUGUSTUS	  assigns	  a	  joint	  probablility	  and	  then	  finds	  the	  gene	  structure	  that	  maximizes	  the	  posterior	  probability.	  The	  software	  is	  available	  at	  http://bioinf.uni-­‐greifswald.de/augustus.	  
1.1.	  AUGUSTUS	  all	  AUGUSTUS	  was	  run	  using	  gene	  expression	  evidence	  generated	  from	  RNA-­‐seq	  data.	  All	  reconstructed	  transcripts	  are	  reported.	  
1.2.	  AUGUSTUS	  high	  AUGUSTUS	  was	  run	  using	  gene	  expression	  evidence	  generated	  from	  RNA-­‐seq	  data.	  Only	  genes	  with	  RPKM	  >	  0	  are	  reported.	  
1.3.	  AUGUSTUS	  de-­‐novo	  AUGUSTUS	  was	  run	  purely	  on	  the	  genomic	  sequences.	  No	  RNA-­‐seq	  information	  is	  provided.	  	  
1.4	  Additional	  features	  AUGUSTUS	  can	  optionally	  make	  use	  of	  protein	  homology	  information	  to	  identify	  coding	  genes.	  Other	  types	  of	  external	  transcriptomic	  information	  can	  also	  be	  incorporated,	  such	  as	  SAGE	  or	  CAGE	  data.	  
2.	  Cufflinks	  Cufflinks	  is	  designed	  to	  reconstruct	  transcripts	  using	  RNA-­‐seq	  reads	  mapped	  to	  the	  genome	  with	  the	  aligner	  TopHat3,	  but	  can	  also	  process	  output	  from	  other	  spliced	  aligners.	  A	  overlap	  graph	  is	  generated	  based	  on	  the	  read	  alignments,	  including	  both	  spliced	  and	  unspliced	  mappings.	  Reads	  that	  are	  incompatible,	  i.e.	  must	  have	  originated	  from	  different	  transcript	  isoforms,	  are	  not	  connected	  in	  the	  graph,	  whereas	  compatbile	  reads	  are	  connected.	  Paths	  through	  the	  graph	  correspond	  to	  different	  transcript	  isoforms.	  The	  Cufflinks	  algorithm	  aims	  to	  find	  a	  minimal	  set	  of	  paths	  that	  covers	  all	  fragments,	  by	  searching	  for	  the	  largest	  set	  of	  reads	  with	  the	  property	  that	  no	  two	  of	  them	  could	  have	  originated	  from	  the	  same	  transcript	  isoform.	  	  	  Here,	  Cufflinks	  version	  2.0.2	  was	  used	  together	  with	  TopHat	  version	  2.0.3.	  Both	  programs	  were	  executed	  with	  intron	  settings	  tailored	  to	  the	  characteristics	  of	  each	  species:	  minimum	  intron	  lengths	  were	  set	  to	  30,	  40,	  and	  50	  bp	  for	  C.	  elegans,	  D.	  melanogaster,	  and	  H.	  sapiens,	  respectively.	  The	  software	  can	  be	  obtained	  from	  http://cufflinks.cbcb.umd.edu.	  	  
2.1	  Additional	  features	  Cufflinks	  can	  optionally	  be	  provided	  with	  genome	  annotation	  to	  improve	  transcript	  assembly.	  Two	  modes	  of	  operation	  are	  implemented:	  the	  first	  will	  use	  annotation	  as	  a	  guide,	  but	  novel	  transcript	  isoforms	  are	  still	  predicted;	  the	  second	  mode	  uses	  RNA-­‐seq	  data	  solely	  to	  quantify	  annotated	  transcripts.	  Cufflinks	  offers	  additional	  options	  to	  correct	  for	  fragment	  bias	  and	  improve	  transcript	  assembly	  by	  estimating	  the	  expected	  pre-­‐mRNA	  fraction	  within	  the	  sample.	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3.	  Exonerate	  SM	  This	  method,	  which	  is	  based	  on	  Exonerate4,	  was	  developed	  by	  Steve	  Searle	  and	  colleagues	  at	  the	  Wellcome	  Trust	  Sanger	  Institute	  (http://www.sanger.ac.uk).	  Briefly,	  sequencing	  reads	  are	  aligned	  to	  the	  genome	  and	  processed	  to	  build	  approximate	  transcript	  models.	  This	  is	  followed	  by	  a	  refinement	  stage,	  where	  reads	  are	  realigned	  against	  the	  models	  using	  a	  method	  that	  takes	  splicing	  signals	  into	  account.	  Exonerate	  SM	  is	  currently	  unreleased.	  
3.1.	  Exonerate	  SM	  high	  This	  set	  of	  transcripts	  contains	  the	  highest	  scoring	  model	  for	  each	  locus	  only.	  
3.2.	  Exonerate	  SM	  all	  This	  output	  contains	  additional	  alternative	  isoforms.	  
4.	  GSTRUCT	  The	  GSTRUCT	  pipeline	  was	  developed	  by	  Thomas	  Wu	  and	  colleagues	  at	  Genentech.	  GSTRUCT	  uses	  bounded	  graph	  analysis	  to	  assemble	  transcripts	  based	  on	  RNA-­‐seq	  read	  mappings	  produced	  with	  the	  aligner	  GSNAP13.	  GSTRUCT	  is	  currently	  unreleased,	  but	  GSNAP	  can	  be	  obtained	  from	  http://research-­‐pub.gene.com/gmap.	  	  
5.	  iReckon	  The	  iReckon	  algorithm	  first	  uses	  spliced	  alignments,	  and	  if	  applicable	  annotated	  introns,	  to	  build	  a	  splice	  graph5.	  All	  possible	  transcript	  isoforms	  are	  then	  identifed	  by	  enumerating	  paths	  from	  each	  of	  the	  possible	  transcription	  start	  sites	  to	  the	  end	  sites.	  For	  each	  putative	  isoform,	  the	  sequence	  is	  extracted	  and	  reads	  are	  realigned	  using	  the	  program	  BWA14.	  Finally,	  expressed	  isoforms	  and	  their	  abundances	  are	  predicted	  by	  a	  regularized	  expectation	  maximization	  algorithm,	  which	  penalizes	  low-­‐abundance	  isoforms.	  iReckon	  also	  reports	  pre-­‐spliced	  mRNAs	  and	  isoforms	  with	  retained	  introns.	  	  iReckon	  version	  1.0.7	  was	  applied	  using	  initial	  alignments	  from	  TopHat	  version	  2.0.3	  and	  BWA	  version	  0.6.2	  for	  realignment.	  These	  software	  components	  are	  available	  from	  http://compbio.cs.toronto.edu/ireckon,	  http://tophat.cbcb.umd.edu	  and	  http://bio-­‐bwa.sourceforge.net,	  respectively.	  	  	  5.1	  iReckon	  full	  The	  program	  was	  provided	  with	  complete	  annotation	  for	  protein	  coding	  genes.	  Unspliced	  or	  retained	  intron	  transcripts	  and	  were	  removed	  from	  the	  program	  output	  so	  as	  not	  to	  bias	  evaluations	  based	  on	  protein-­‐coding	  annotation.	  	  5.2	  iReckon	  ends	  The	  program	  was	  provided	  with	  transcript	  boundary	  coordinates	  (start	  and	  end	  coordinates,	  but	  not	  intron	  information)	  from	  the	  reference	  annotation	  used	  for	  the	  evaluation.	  Unspliced	  transcripts	  were	  removed	  from	  the	  program	  output	  so	  as	  not	  to	  bias	  evaluations	  based	  on	  protein-­‐coding	  annotation.	  	  
5.3	  Additional	  features	  iReckon	  can	  predict	  pre-­‐mRNAs	  and	  retained	  introns	  from	  RNA-­‐seq	  data.	  The	  software	  distribution	  also	  includes	  a	  plug-­‐in	  for	  the	  Savant	  Genome	  Browser	  to	  visualize	  read	  assignment	  to	  transcript	  isoforms.	  
6.	  mGene	  and	  mTim	  The	  protocols	  mGene,	  mGene	  graph	  and	  mTim	  are	  based	  on	  combinations	  of	  the	  individual	  programs	  PALMapper15,	  mGene6,16,	  mTim,	  SplAdder	  and	  rQuant17,	  all	  developed	  by	  the	  same	  group.	  	  	  PALMapper	  was	  used	  to	  align	  the	  RNA-­‐seq	  reads	  by	  allowing	  spliced	  and	  unspliced	  alignments.	  The	  program	  considers	  base	  call	  quality	  scores	  and	  computational	  splice	  site	  predictions	  during	  alignment.	  Alignments	  were	  filtered	  with	  different	  settings	  for	  mGene	  and	  mTim	  (see	  below).	  	  The	  basic	  mGene	  algorithm	  uses	  a	  two-­‐layered	  machine	  learning	  approach.	  The	  first	  layer	  employs	  support	  vector	  machine	  models	  to	  scan	  genomic	  sequence	  for	  transcription	  start	  and	  stop	  sites,	  translation	  start	  and	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stop	  sites,	  and	  splice	  donors	  and	  acceptors.	  The	  second	  uses	  hidden	  semi-­‐Markov	  support	  vector	  machines	  to	  combine	  those	  features	  into	  valid	  coding	  gene	  predictions.	  While	  the	  fundamental	  strategy	  relies	  only	  on	  genomic	  sequence,	  mGene	  can	  also	  include	  information	  from	  features	  tracks	  in	  the	  scoring	  function.	  Various	  tracks	  were	  used	  in	  this	  protocol,	  mostly	  from	  RNA-­‐seq	  alignments.	  The	  balance	  between	  signal	  predictions	  and	  feature	  tracks	  is	  optimized	  during	  training.	  This	  extension	  of	  mGene	  has	  recently	  been	  documented.	  	  In	  contrast	  to	  mGene,	  mTim	  uses	  a	  simpler	  hidden	  Markov	  support	  vector	  machine	  approach,	  in	  which	  states	  directly	  correspond	  to	  intergenic,	  exonic	  and	  intronic	  nucleotides	  with	  a	  certain	  expression	  level	  (five	  submodels	  were	  used,	  each	  corresponding	  to	  an	  expression	  quintile).	  Based	  on	  features	  derived	  from	  the	  RNA-­‐seq	  alignments,	  the	  most	  likely	  state	  is	  inferred	  for	  each	  nucleotide,	  taking	  context-­‐dependencies	  into	  account	  (in	  the	  form	  of	  a	  state-­‐transition	  model).	  The	  model	  does	  not	  distinguish	  between	  coding	  and	  non-­‐coding	  regions.	  The	  parameters	  of	  the	  model	  are	  trained	  on	  a	  small	  subset	  of	  the	  reference	  gene	  annotation.	  	  	  SplAdder	  builds	  a	  splice	  graph	  based	  on	  initial	  predictions	  and	  RNA-­‐seq	  evidence.	  The	  splice	  graph	  is	  then	  used	  to	  generate	  possible	  transcript	  isoforms.	  For	  each	  transcript	  SplAdder	  determines	  the	  maximal	  open	  reading	  frame	  to	  predict	  coding	  regions.	  	  Expression	  levels	  of	  predicted	  isoforms	  were	  estimated	  using	  the	  program	  rQuant	  that	  can	  take	  fragment	  biases	  into	  account.	  Those	  transcripts	  that	  scored	  low	  using	  an	  SVM	  classifier	  were	  removed	  from	  the	  prediction	  set.	  The	  SVM	  was	  trained	  on	  a	  small	  fraction	  of	  the	  genome	  annotation	  using	  estimated	  abundance,	  length,	  coding	  sequence	  length	  and	  number	  of	  exons	  as	  features.	  	  The	  programs	  PALMapper,	  mGene,	  mTim,	  SplAdder,	  and	  rQuant	  can	  be	  obtained	  from	  http://raetschlab.org/suppl/rgasp2.	  	  	  Based	  on	  these	  algorithms,	  prediction	  sets	  were	  created	  as	  follows:	  
6.1.	  mGene	  For	  each	  organism	  mGene	  was	  trained	  with	  multiple	  features	  from	  PALMapper	  RNA-­‐seq	  alignments,	  as	  well	  as	  other	  genomic	  features,	  output	  from	  SVM-­‐based	  signal	  predictors	  that	  were	  previously	  trained	  on	  a	  part	  of	  the	  annotation.	  The	  RNA-­‐seq	  based	  features	  included	  exon	  coverage,	  intron	  coverage	  (number	  of	  spliced	  reads	  spanning	  a	  given	  position,	  indicating	  that	  this	  position	  may	  be	  part	  of	  an	  intron)	  and	  intron	  lists	  including	  the	  count	  of	  supporting	  reads.	  Alignments	  were	  filtered	  by	  excluding	  reads	  with	  more	  than	  one	  mismatch,	  fewer	  than	  eight	  aligned	  nucleotides	  in	  any	  exon	  flanking	  a	  spliced	  alignment,	  or	  a	  spliced	  alignment	  indicating	  and	  intron	  longer	  than	  20	  kb	  (100	  kb	  for	  human).	  	  	  For	  human,	  repeat	  elements	  identified	  by	  RepeatMasker	  were	  included,	  in	  addition	  to	  other	  sequence-­‐based	  features.	  Similar	  to	  exon	  and	  intron	  coverage	  tracks,	  15	  additional	  tracks	  were	  included:	  "DNA",	  "LINE",	  "Low_complexity",	  "LTR",	  "Other",	  "RC",	  "tRNA",	  "Satellite",	  "Simple_repeat",	  "SINE",	  "Unknown",	  "rRNA",	  "scRNA",	  "snRNA"	  and	  "RNA".	  	  
6.2.	  mGene	  graph	  As	  the	  mGene	  protocol	  above,	  with	  the	  addition	  that	  alternative	  transcripts	  were	  predicted	  using	  SplAdder,	  subsequently	  quantified	  using	  rQuant	  and	  filtered	  using	  the	  SVM	  classifier.	  
6.3.	  mTim	  RNA-­‐seq	  alignments	  generated	  by	  PALMapper	  were	  filtered	  specifically	  for	  each	  organism.	  Spliced	  alignments	  for	  C.	  elegans,	  D.	  melanogaster	  and	  H.	  sapiens	  were	  filtered	  out	  if	  the	  minimal	  segment	  length	  within	  an	  alignment	  was	  shorter	  than	  15nt,	  20nt,	  or	  15nt,	  respectively.	  A	  general	  threshold	  of	  at	  most	  one	  edit	  operation	  was	  applied	  to	  all	  alignments	  for	  all	  organisms.	  	  	  mTim	  was	  trained	  with	  multiple	  features	  from	  RNA-­‐seq	  alignments	  as	  well	  as	  splice	  signals	  from	  genomic	  sequence	  (based	  on	  an	  SVM	  classifier	  previously	  trained	  on	  a	  subset	  of	  the	  annotation).	  Features	  derived	  from	  the	  RNA-­‐seq	  alignments	  included	  exon	  coverage,	  intron	  coverage	  (number	  of	  spliced	  reads	  spanning	  a	  given	  position),	  scores	  for	  acceptor	  and	  donor	  splice	  sites	  deduced	  from	  spliced	  alignments	  (number	  of	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spliced	  alignments	  with	  a	  given	  junction	  and	  alignment	  confidence	  scores)	  as	  well	  as	  mate-­‐pair	  coverage	  (number	  of	  read	  pairs	  with	  an	  insert	  spanning	  a	  given	  position).	  SplAdder	  was	  applied	  to	  the	  raw	  mTim	  transcript	  predictions	  to	  generate	  alternative	  transcripts,	  which	  were	  quantified	  by	  rQuant	  and	  filtered	  using	  the	  SVM	  approach.	  
7.	  NextGeneid	  NextGeneid	  is	  a	  modified	  version	  of	  Geneid	  (version	  1.3)8.	  Geneid	  identifies	  splice	  sites	  and	  start/stop	  codons	  from	  genomic	  sequence.	  These	  features	  are	  then	  combined	  to	  predict	  exons,	  which	  are	  scored	  based	  on	  supporting	  features	  and	  coding	  potential.	  From	  the	  set	  of	  predicted	  exons,	  gene	  structures	  are	  assembled.	  NextGeneid	  additionally	  incorporates	  RNA-­‐seq	  read	  alignments	  to	  the	  genome,	  produced	  with	  the	  GEM	  mapper18,	  including	  spliced	  alignments	  from	  the	  GEM	  component	  gem-­‐split-­‐mapper.	  Read	  alignments	  were	  used	  to	  modify	  the	  scores	  of	  potential	  exons,	  determine	  transcript	  start	  and	  end	  coordinates,	  and	  constrain	  the	  exon-­‐chaining	  algorithm	  in	  Geneid	  based	  on	  spliced	  alignments.	  NextGeneid	  has	  not	  been	  released.	  
7.1.	  NextGeneid	  Geneid	  was	  previously	  trained	  on	  several	  species,	  including	  the	  three	  used	  in	  this	  study.	  No	  modifications	  to	  the	  signal	  or	  coding	  potential	  position	  weight	  arrays	  were	  performed.	  Transcripts	  reported	  by	  NextGeneid	  with	  RPKM	  >	  1	  were	  retained.	  
7.2.	  NextGeneidAS	  As	  NextGeneid,	  but	  iterated	  to	  increase	  intron	  detection	  sensitivity.	  
7.3.	  NextGeneidAS	  de-­‐novo	  As	  NextGeneid,	  with	  the	  addition	  of	  ab	  initio	  Geneid	  predictions	  falling	  within	  intergenic	  space	  to	  the	  final	  set	  of	  transcripts.	  
8.	  Oases	  Oases	  assembles	  transcripts	  from	  RNA-­‐seq	  data	  without	  using	  genomic	  sequence9.	  It	  is	  based	  on	  the	  short-­‐read	  assembler	  Velvet12,	  adapting	  several	  steps	  to	  the	  different	  characteristics	  of	  RNA-­‐seq	  data,	  such	  as	  uneven	  coverage	  across	  transcripts	  and	  the	  expression	  of	  alternative	  isoforms.	  Reads	  of	  low	  quality	  were	  first	  removed	  from	  the	  data	  and	  low-­‐quality	  bases	  were	  trimmed	  from	  from	  both	  ends	  of	  reads.	  Velvet	  was	  then	  used	  to	  build	  a	  de	  Bruijn	  graph	  from	  the	  RNA-­‐seq	  data	  using	  a	  k-­‐mer	  size	  of	  33.	  Mate	  pair	  and	  coverage	  information	  was	  used	  to	  predict	  and	  assemble	  transcripts	  using	  Oases	  v0.1.	  The	  resulting	  transcripts	  were	  then	  aligned	  to	  each	  genome	  using	  BLAT19.	  Oases	  is	  available	  at	  http://www.ebi.ac.uk/~zerbino/oases.	  
9.	  SLIDE	  SLIDE	  is	  a	  stochastic	  method	  based	  on	  a	  linear	  model	  with	  a	  design	  matrix	  that	  computes	  the	  sampling	  probability	  of	  RNA-­‐seq	  reads	  from	  different	  transcript	  isoforms10.	  It	  utilizes	  exon	  boundary	  information	  from	  annotations	  to	  enumerate	  all	  possible	  isoforms.	  Discovery	  of	  expressed	  isoforms	  is	  implemented	  as	  a	  sparse	  estimation	  problem,	  related	  to	  the	  number	  of	  isoforms	  that	  are	  expected	  to	  be	  expressed.	  Sparse	  estimation	  is	  achieved	  by	  a	  modified	  lasso	  method20.	  SLIDE	  is	  available	  at	  https://sites.google.com/site/jingyijli.	  
9.1.	  SLIDE	  all	  All	  transcript	  isoforms	  reported	  by	  SLIDE.	  
9.2.	  SLIDE	  high	  The	  subset	  of	  isoforms	  identified	  as	  “high	  confidence”	  by	  SLIDE.	  
10.	  Transomics	  The	  Transomics	  pipeline	  is	  based	  on	  the	  gene	  finding	  pipeline	  Fgenesh++21,	  extended	  to	  incoporate	  splice	  site	  information	  from	  RNA-­‐seq	  read	  mappings	  to	  the	  genome.	  The	  relative	  abundance	  of	  alternative	  transcripts	  generated	  from	  the	  same	  gene	  locus	  is	  estimated	  using	  a	  solution	  of	  a	  system	  of	  linear	  equations.	  Further	  details	  are	  available	  at	  http://linux5.softberry.com/cgi-­‐bin/berry/programs/Transomics.	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10.1.	  Transomics	  all	  All	  predicted	  genes	  are	  reported.	  
10.2.	  Transomics	  high	  Only	  transcripts	  with	  RPKM	  >	  0.02	  are	  reported.	  
11.	  Trembly	  Trembly	  is	  an	  unpublished	  software	  package	  for	  transcript	  reconstruction	  from	  RNA-­‐seq	  data	  developed	  in	  Mark	  Gerstein’s	  group	  at	  Yale	  University	  (http://www.gersteinlab.org).	  Trembly	  was	  applied	  to	  RNA-­‐seq	  reads	  aligned	  with	  TopHat.	  A	  signal	  track	  of	  mapped	  reads	  is	  generated	  and	  a	  set	  of	  transcriptionally	  active	  regions	  (TARs)	  is	  identified.	  Splice	  junctions	  are	  then	  inferred	  from	  adjacent	  TARs.	  Both	  the	  predicted	  splice	  junctions	  and	  TARs	  are	  provided	  as	  input	  for	  transcript	  assembly,	  which	  generates	  all	  possible	  transcript	  isoforms	  compatible	  with	  the	  data.	  Expression	  levels	  of	  predicted	  transcripts	  were	  estimated	  using	  the	  program	  IQSeq	  developed	  by	  the	  same	  group22.	  
11.1.	  Trembly	  all	  The	  full	  output	  from	  Trembly.	  
11.2.	  Trembly	  high	  The	  subset	  of	  transcripts	  with	  RPKM	  above	  0.1.	  
12.	  Tromer	  The	  Tromer	  pipeline	  first	  maps	  reads	  to	  the	  genome	  using	  fetchGWI	  to	  identify	  unique	  exact	  matches11.	  MegaBLAST	  is	  used	  to	  recover	  unmapped	  reads.	  In	  a	  third	  step,	  spliced	  alignment	  is	  carried	  out	  with	  SIBsim4,	  taking	  mate	  pair	  information	  into	  account.	  The	  output	  of	  these	  three	  steps	  is	  combined	  to	  create	  graphs	  representing	  all	  possible	  alternative	  splice	  variants	  of	  a	  gene.	  A	  greedy	  algorithm	  is	  applied	  to	  the	  graphs,	  designed	  to	  output	  a	  set	  of	  transcripts	  such	  that	  each	  edge	  is	  covered	  at	  least	  once.	  The	  algorithm	  proceeds	  in	  three	  steps:	  1)	  select	  a	  seed	  edge,	  2)	  extend	  toward	  the	  5´	  end,	  and	  3)	  extend	  toward	  the	  3´	  end.	  The	  seed	  edge	  is	  first	  selected	  among	  unused	  5´-­‐most	  exons,	  and	  then	  among	  remaining	  unused	  edges.	  The	  extension	  process	  attempts	  to	  include	  unused	  edges	  derived	  from	  the	  same	  read	  pair	  as	  the	  seed	  edge.	  Further	  details	  are	  available	  at	  http://tromer.sourceforge.net.	  
13.	  Velvet	  These	  protocols	  are	  based	  on	  the	  genome	  assembly	  program	  Velvet12.	  Transcripts	  assembled	  by	  Velvet	  were	  mapped	  to	  the	  respective	  genomes	  using	  BLAT19.	  Exons	  were	  quantified	  using	  ERANGE23.	  These	  programs	  are	  available	  from	  http://www.ebi.ac.uk/~zerbino/velvet,	  http://genome.ucsc.edu	  (BLAT)	  and	  http://woldlab.caltech.edu	  (ERANGE).	  
13.1.	  Velvet	  This	  protocol	  corresponds	  to	  the	  Velvet	  pipeline	  outlined	  above.	  
13.2.	  Velvet	  +	  Augustus	  Transcripts	  structures	  assembled	  by	  the	  Velvet	  pipeline	  were	  provided	  to	  AUGUSTUS	  as	  evidence.	  The	  final	  set	  of	  transcripts	  consisted	  of	  AUGUSTUS	  models	  that	  agreed	  with	  the	  original	  isoforms	  from	  Velvet	  over	  more	  than	  25%	  of	  their	  length.	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